image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
3714382913748d8ea88821b07694f647a8cff42119a58c1304c25779d78fff4a.png | simple | <table><tr><td>International source</td><td>Range of time requirement in minutes</td><td>Average time requirement in minutes</td></tr><tr><td>ECDC Round Table Report</td><td>< 15–60</td><td>40</td></tr><tr><td>ProMED-mail</td><td>< 15–45</td><td>35</td></tr><tr><td>WHO Event Information Site (EIS)</td... | <table><tr><td>International source</td><td>Range of time requirement in minutes</td><td>Average time requirement in minutes</td></tr><tr><td>ECDC Round Table Report</td><td>< 15–60</td><td>40</td></tr><tr><td>ProMED-mail</td><td>< 15–45</td><td>35</td></tr><tr><td>WHO Event Information Site (EIS)</td><td>< 15–30</td><... | <table><tr><td>International source</td><td>Range of time requirement in minutes</td><td>Average time requirement in minutes</td></tr><tr><td>WHO Weekly Epidemiological Records (WER)</td><td>< 15</td><td>10</td></tr><tr><td>TOTAL</td><td>150–330</td><td>230</td></tr></table> |
193f0d8965386c37de081d2193fcfbf1d5427efb9bf7c98aa56f55e9bf58cf77.png | simple | <table><tr><td>Agent</td><td>Specific mechanism</td><td>Highest level of studies</td><td>Result</td></tr><tr><td>Tauroursodeoxycholic acid</td><td>Chemical chaperone</td><td>Randomized controlled trials</td><td>Improved insulin sensitivity in muscle and liver in obese individuals [86]</td></tr><tr><td>Phenylbutyrate</t... | <table><tr><td>Agent</td><td>Specific mechanism</td></tr><tr><td>Tauroursodeoxycholic acid</td><td>Chemical chaperone</td></tr><tr><td>Phenylbutyrate</td><td>Chemical chaperone</td></tr><tr><td>Azoramide</td><td>ATF6 activators</td></tr><tr><td>Valproate</td><td>Increasing GRPP78</td></tr><tr><td>L-Carnitine or carniti... | <table><tr><td>Highest level of studies</td><td>Result</td></tr><tr><td>Randomized controlled trials</td><td>Improved insulin sensitivity in muscle and liver in obese individuals [86]</td></tr><tr><td>Randomized controlled trials</td><td>Improved insulin sensitivity and beta-cell function in lipid-infused individuals [... |
9fa195cab3b7a4379d25c9cb0e2276539a4c8e27ca359914e4c6b4b06c5c97fe.png | complex | <table><tr><td>Factor</td><td>Parameter Estimate (95% CI)</td><td><i>P</i></td></tr><tr><td colspan="3">Mean arterial blood pressure</td></tr><tr><td> Smoker</td><td>3.49 (−2.67, 9.64)</td><td>.257</td></tr><tr><td> Male sex</td><td>−38.45 (−91.78 to 14.88)</td><td>.151</td></tr><tr><td> Age</td><td>0... | <table><tr><td>Factor</td><td>Parameter Estimate (95% CI)</td><td>P</td></tr><tr><td colspan="3">Mean arterial blood pressure</td></tr><tr><td>Smoker</td><td>3.49 (−2.67, 9.64)</td><td>.257</td></tr><tr><td>Male sex</td><td>−38.45 (−91.78 to 14.88)</td><td>.151</td></tr><tr><td>Age</td><td>0.25 (−.14 to .64)</td><td>.2... | <table><tr><td>Male sex</td><td>−62.14 (−119.59 to −4.70)</td><td>.035</td></tr><tr><td>Age</td><td>−0.04 (−.45 to .38)</td><td>.858</td></tr><tr><td>Body mass index</td><td>0.44 (−.42 to 1.30)</td><td>.301</td></tr><tr><td>Antihypertensive</td><td>1.86 (−5.28 to 8.99)</td><td>.600</td></tr><tr><td>CD4+ iTreg count, pe... |
95561406731589159c1934921b1caee32715761e2f3803c4b9af45707ae0a466.png | complex | <table><tr><td rowspan="2">Parameter</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>HR(95% CI)</td><td>P-value</td><td>HR (95% CI)</td><td>P-value</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>1(Referent)</td><td></td><td>... | <table><tr><td rowspan="2">Parameter</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>HR(95% CI)</td><td>P-value</td><td>HR (95% CI)</td><td>P-value</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>1(Referent)</td><td></td><td>... | <table><tr><td>I+II</td><td>1(Referent)</td><td></td><td></td><td></td></tr><tr><td>III+IV</td><td>11.791(3.728-37.225)</td><td><0.001</td><td>4.757(1.316-17.201)</td><td>0.017</td></tr><tr><td>GGT</td><td></td><td></td><td></td><td></td></tr><tr><td><23</td><td>1(Referent)</td><td></td><td></td><td></td></tr><tr><td>≥... |
2d5bed8c96e87abe7b35e4c0db823e04533cdc38a9d57f89a19f2085879f02cb.png | complex | <table><tr><td>Cat no.</td><td>Category</td><td>No. of questions</td></tr><tr><td colspan="2">Questionnaire 1 (QS1)</td><td>24</td></tr><tr><td>n/a</td><td>Have you ever heard of <i>masese</i>a?</td><td>1</td></tr><tr><td>1</td><td>Acquisition & transmission of <i>T. solium</i> infections</td><td>3</td></tr><tr><td... | <table><tr><td>Cat no.</td><td>Category</td><td>No. of questions</td></tr><tr><td colspan="2">Questionnaire 1 (QS1)</td><td>24</td></tr><tr><td>n/a</td><td>Have you ever heard of masesea?</td><td>1</td></tr><tr><td>1</td><td>Acquisition & transmission of T. solium infections</td><td>3</td></tr></table> | <table><tr><td>2</td><td>Acquisition of NCC</td><td>2</td></tr><tr><td>3</td><td>TS in general</td><td>3</td></tr><tr><td>4</td><td>NCC in general</td><td>3</td></tr><tr><td>5</td><td>PCC diagnosis</td><td>4</td></tr><tr><td>6</td><td>PCC treatment</td><td>2</td></tr><tr><td>7</td><td>Relationship between PCC/TS/NCC</t... |
155dcd3e15cacbd46fedd8c903d4b3291629a27923b11ce6bd80ebae47f5b6a8.png | simple | <table><tr><td><i>CD274/PD-L1</i> FISH</td><td>Cases</td><td>PD-L1 IHC</td><td></td><td></td><td></td></tr><tr><td></td><td><i>n</i> = 80</td><td>Score3+</td><td>Score2+</td><td>Score1+</td><td>Score0</td></tr><tr><td>High Level Amplification</td><td>12 (15%)</td><td>7/12</td><td>1/12</td><td>2/12</td><td>2/12</td></tr... | <table><tr><td>CD274/PD-L1 FISH</td><td>Cases</td><td>PD-L1 IHC</td><td></td><td></td><td></td></tr><tr><td></td><td>n = 80</td><td>Score3+</td><td>Score2+</td><td>Score1+</td><td>Score0</td></tr><tr><td>High Level Amplification</td><td>12 (15%)</td><td>7/12</td><td>1/12</td><td>2/12</td><td>2/12</td></tr><tr><td>Low L... | <table><tr><td>Disomy</td><td>49 (61%)</td><td>3/49</td><td>8/49</td><td>5/49</td><td>33/49</td></tr></table> |
544e4eb350941ed21f388455939329039a819a7aa14bb303a488a9f84657ef03.png | simple | <table><tr><td> </td><td>Total (N=60)</td><td>Group 1 (N=39, 65%)</td><td>Group 2 (N=21, 35%)</td><td><i>P </i>value</td></tr><tr><td>HPV-HR</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Positive</td><td>23 (56)</td><td>14 (61)</td><td>9 (50)</td><td>0.54</td></tr><tr><td>Negative</td><td>18 (44)</td><td>9 (... | <table><tr><td></td><td>Total (N=60)</td><td>Group 1 (N=39, 65%)</td><td>Group 2 (N=21, 35%)</td><td>P value</td></tr><tr><td>HPV-HR</td><td></td><td></td><td></td><td></td></tr><tr><td>Positive</td><td>23 (56)</td><td>14 (61)</td><td>9 (50)</td><td>0.54</td></tr><tr><td>Negative</td><td>18 (44)</td><td>9 (39)</td><td>... | <table><tr><td></td><td>Total (N=60)</td><td>Group 1 (N=39, 65%)</td><td>Group 2 (N=21, 35%)</td><td>P value</td></tr><tr><td>Negative</td><td>14 (34)</td><td>7 (30)</td><td>7 (39)</td><td></td></tr><tr><td>Cyclin D1</td><td></td><td></td><td></td><td></td></tr><tr><td>Positive</td><td>12 (29)</td><td>4 (17)</td><td>8 ... |
7b18d8b726f82e1b80ab6b07eb34f2c08fa5aa0bebc16825d349e2301c3e8e90.png | simple | <table><tr><td>Statement</td><td>Agree (%)</td><td>Disagree (%)</td><td>? (%)</td></tr><tr><td>1. A man doesn't reach a orgasm during sexual intercourse. Still, the woman can become pregnant.</td><td>50</td><td>34</td><td>16</td></tr><tr><td>2. It is unhealthy to use the oral contraceptive pill for a period longer than... | <table><tr><td>Statement</td><td>Agree (%)</td><td>Disagree (%)</td><td>? (%)</td></tr><tr><td>1. A man doesn't reach a orgasm during sexual intercourse. Still, the woman can become pregnant.</td><td>50</td><td>34</td><td>16</td></tr><tr><td>2. It is unhealthy to use the oral contraceptive pill for a period longer than... | <table><tr><td>7. An intrauterine device can reside in the uterus without problems for 5 years.</td><td>42</td><td>20</td><td>38</td></tr><tr><td>8. A condom is not reliable because it ruptures rapidly.</td><td>39</td><td>53</td><td>8</td></tr></table> |
25e0fe3b39008208ea823b47f8d4fd9c4cdac157a2cc54aa8aff4ae4ad46d21a.png | simple | <table><tr><td></td><td>Without vaccination</td><td>With vaccination<sup>a</sup></td><td>Difference</td></tr><tr><td>Cases<sup>b</sup></td><td>59,495</td><td>25,281</td><td>34,214</td></tr><tr><td> Treated at home</td><td>47,622</td><td>22,389</td><td>25,232</td></tr><tr><td> GP visits</td><td>11,453</td><td>2,786</td>... | <table><tr><td></td></tr><tr><td>Casesb</td></tr><tr><td>Treated at home</td></tr><tr><td>GP visits</td></tr><tr><td>Hospitalised (community acquired)</td></tr><tr><td>Hospitalised (nosocomial)</td></tr><tr><td>Deaths</td></tr><tr><td>Total QALYs lostc</td></tr><tr><td>Total direct costsa (x1000)c</td></tr><tr><td>Tota... | <table><tr><td>Without vaccination</td><td>With vaccinationa</td><td>Difference</td></tr><tr><td>59,495</td><td>25,281</td><td>34,214</td></tr><tr><td>47,622</td><td>22,389</td><td>25,232</td></tr><tr><td>11,453</td><td>2,786</td><td>8,667</td></tr><tr><td>2,817</td><td>353</td><td>2,464</td></tr><tr><td>421</td><td>10... |
768a87741a04e7130686072f35025fffbfc372e5127aff85c7c1fbd5b45af6c6.png | complex | <table><tr><td rowspan="2" colspan="2">Characteristics</td><td>HCC n(%)</td><td>CHB n(%)</td><td>HEAL n(%)</td><td><i>P </i>value</td></tr><tr><td>n = 392</td><td>n = 344</td><td>n = 372</td><td> </td></tr><tr><td rowspan="2">Age</td><td><55</td><td>252(64.3)</td><td>223(64.8)</td><td>245(65.9)</td><td>0.90</td></tr... | <table><tr><td rowspan="2" colspan="2">Characteristics</td><td>HCC n(%)</td><td>CHB n(%)</td><td>HEAL n(%)</td></tr><tr><td>n = 392</td><td>n = 344</td><td>n = 372</td></tr><tr><td rowspan="2">Age</td><td><55</td><td>252(64.3)</td><td>223(64.8)</td><td>245(65.9)</td></tr><tr><td>≥55</td><td>140(35.7)</td><td>121(35.2)<... | <table><tr><td>P value</td></tr><tr><td></td></tr><tr><td>0.90</td></tr><tr><td></td></tr><tr><td>0.001</td></tr><tr><td></td></tr><tr><td><0.001</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td><0.001</td></tr><tr><td>0.30</td></tr><tr><td>0.67</td></tr><tr><td... |
2a41e6d30882308285bfff49169a7fb131f9faf7360ead77a4f975c9dc79df67.png | complex | <table><tr><td>Data set</td><td colspan="3">Variance component (%)</td></tr><tr><td></td><td>Among groups</td><td>Among populations within group</td><td>Within populations</td></tr><tr><td>All six cattle breeds</td><td>7.80</td><td>0.70</td><td>91.45</td></tr><tr><td>Indigenous and local developed breeds</td><td>7.80</... | <table><tr><td>Data set</td><td colspan="3">Variance component (%)</td></tr><tr><td></td><td>Among groups</td><td>Among populations within group</td><td>Within populations</td></tr></table> | <table><tr><td>All six cattle breeds</td><td>7.80</td><td>0.70</td><td>91.45</td></tr><tr><td>Indigenous and local developed breeds</td><td>7.80</td><td>1.40</td><td>90.80</td></tr></table> |
960edf1682277fc8d8ac4accdd1ad28cebc0ad3d40a5353d8de7d4d283d80621.png | complex | <table><tr><td rowspan="2">Individual/Demographic</td><td colspan="5">Total Leisure Time Physical Activity (LTPA)</td></tr><tr><td>(ALL) <i>n</i> = 428</td><td>T1 <i>n</i> = 143</td><td>T2 <i>n</i> = 142</td><td>T3 <i>n</i> = 143</td><td><i>p</i> Trend</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td>&l... | <table><tr><td rowspan="2">Individual/Demographic</td><td colspan="5">Total Leisure Time Physical Activity (LTPA)</td></tr><tr><td>(ALL) n = 428</td><td>T1 n = 143</td><td>T2 n = 142</td><td>T3 n = 143</td><td>p Trend</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td><0.001</td></tr><tr><td>Men</td><td>1... | <table><tr><td rowspan="2">Individual/Demographic</td><td colspan="5">Total Leisure Time Physical Activity (LTPA)</td></tr><tr><td>(ALL) n = 428</td><td>T1 n = 143</td><td>T2 n = 142</td><td>T3 n = 143</td><td>p Trend</td></tr><tr><td>en</td><td> (57.5%)</td><td>94 (65.7%)</td><td>64.1%)</td><td>42.7%)</td><td></td></t... |
4e4dff3af35d4ffa04880e73a46cea1f2b642db34a8f19d2530fd430a3c58035.png | complex | <table><tr><td> </td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3</td></tr><tr><td>Characteristics</td><td>Coeff</td><td>(95% CI)</td><td>Coeff</td><td>95% CI</td><td>Coeff</td><td>95% CI</td></tr><tr><td>Sociodemographic</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td... | <table><tr><td></td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3</td></tr><tr><td>Characteristics</td><td>Coeff</td><td>(95% CI)</td><td>Coeff</td><td>95% CI</td><td>Coeff</td><td>95% CI</td></tr><tr><td>Sociodemographic</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><... | <table><tr><td></td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3</td></tr><tr><td>Characteristics</td><td>Coeff</td><td>(95% CI)</td><td>Coeff</td><td>95% CI</td><td>Coeff</td><td>95% CI</td></tr><tr><td>Behavioural</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><t... |
ad39153977dcf1a03e4653fb6e48913bcd02f7e814c7401bc519b7d93c07ff60.png | simple | <table><tr><td></td><td>Unadjusted model (OR; CI95%)</td><td>Model 1 (OR; CI95%)</td><td>Model 2 (OR; CI95%)</td><td>Model 3 (OR; CI95%)</td></tr><tr><td>Glomerular filtration rate (eGFR)</td><td></td><td></td><td></td><td></td></tr><tr><td>eGFR ≥ 60 mL/min/1.73 m<sup>2</sup></td><td>1</td><td>1</td><td>1</td><td... | <table><tr><td></td><td>Unadjusted model (OR; CI95%)</td><td>Model 1 (OR; CI95%)</td><td>Model 2 (OR; CI95%)</td><td>Model 3 (OR; CI95%)</td></tr><tr><td>Glomerular filtration rate (eGFR)</td><td></td><td></td><td></td><td></td></tr><tr><td>eGFR ≥ 60 mL/min/1.73 m2</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><... | <table><tr><td></td><td>Unadjusted model (OR; CI95%)</td><td>Model 1 (OR; CI95%)</td><td>Model 2 (OR; CI95%)</td><td>Model 3 (OR; CI95%)</td></tr><tr><td> mg/gr)</td><td>.1)</td><td>.6 (1.9-10.9)</td><td> (1.8-10.2)</td><td>)</td></tr><tr><td>For each unit above 29 mg/gr</td><td>1.001 (0.99-1.01)</td><td>1.001 (0.99-1.... |
b5fa861a6c0a333080566b6475ffe3381847b0e2c1296a314b6a65003d597fa0.png | complex | <table><tr><td> </td><td colspan="2">Bayes Factor 10</td><td colspan="2">Bayes Factor 30</td><td colspan="2">Bayes Factor 50</td></tr><tr><td> </td><td>Blood</td><td>Brush</td><td>Blood</td><td>Brush</td><td>Blood</td><td>Brush</td></tr><tr><td>Mean # CNVS per subject</td><td>314.0</td><td>385.7</td><td>151.5</td><td>1... | <table><tr><td></td><td colspan="2">Bayes Factor 10</td><td>Bayes Factor 30</td></tr><tr><td></td><td>Blood</td><td>Brush</td><td>Blood</td></tr><tr><td>Mean # CNVS per subject</td><td>314.0</td><td>385.7</td><td>151.5</td></tr><tr><td colspan="4">Size of CNVs (kb)</td></tr><tr><td>Mean</td><td>15.9</td><td>16.2</td><t... | <table><tr><td>Bayes Factor 30</td><td colspan="2">Bayes Factor 50</td></tr><tr><td>Brush</td><td>Blood</td><td>Brush</td></tr><tr><td>183.0</td><td>103.1</td><td>109.1</td></tr><tr><td colspan="3">Size of CNVs (kb)</td></tr><tr><td>19.0</td><td>19.4</td><td>19.0</td></tr><tr><td>1.1</td><td>1.1</td><td>1.2</td></tr><t... |
c2c50d4447415b878adf73b52e0e0e301622ea6fdb6a87f6f605e53bf556f245.png | complex | <table><tr><td></td><td colspan="4">Practices in first cohort</td><td colspan="2">Practices in second cohort</td></tr><tr><td>Practice characteristic</td><td colspan="2">2006-2008</td><td colspan="2">2009-2011</td><td colspan="2">2009-2011</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</t... | <table><tr><td></td><td colspan="4">Practices in first cohort</td><td colspan="2">Practices in second cohort</td></tr><tr><td>Practice characteristic</td><td colspan="2">2006-2008</td><td colspan="2">2009-2011</td><td colspan="2">2009-2011</td></tr></table> | <table><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>Practice type</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Single handed</td><td>17</td><td>25%</td><td>18</td><td>26%</td><td>19</td><td>27%</td></tr><tr><td>Health center</td><td>10</td><td>14%</td><... |
741e594f762f5ab3686054f02af8a0c325f5259caf1e84675ec99ae3c5898f66.png | complex | <table><tr><td></td><td colspan="2">Females</td><td colspan="2">Males</td></tr><tr><td></td><td>Control</td><td>Prenatal stress</td><td>Control</td><td>Prenatal stress</td></tr><tr><td>P1</td><td>6.4 ± 1.1</td><td>5.9 ± 1.5<sup><i>aa</i></sup></td><td>6.7 ± 1.3</td><td>6.2 ± 1.6</td></tr><tr><td>P21... | <table><tr><td></td><td colspan="2">Females</td><td>Males</td></tr><tr><td></td><td>Control</td><td>Prenatal stress</td><td>Control</td></tr><tr><td>P1</td><td>6.4 ± 1.1</td><td>5.9 ± 1.5aa</td><td>6.7 ± 1.3</td></tr><tr><td>P21</td><td>40.8 ± 2.4</td><td>39.8 ± 2.1</td><td>39.5 ± 2.2</td></tr><tr><td>P28</td><td>57.8 ... | <table><tr><td>Males</td></tr><tr><td>Prenatal stress</td></tr><tr><td>6.2 ± 1.6</td></tr><tr><td>43.2 ± 2.7</td></tr><tr><td>66.2 ± 2.8</td></tr></table> |
9aecdc9ee349f5dc3eb68074538aedee75eefb37c0eed27f3b51bcf26dbd896a.png | simple | <table><tr><td>Storage time</td><td>Test organism exposed to (name of the test)</td><td><i>Staphylococcus </i><i>aureus</i></td><td><i>Staphylococcus </i><i>epidermidis</i></td><td><i>Micrococcus </i><i>luteus</i></td><td><i>Corynebacterium </i><i>jeikeium</i></td><td><i>Candida </i><i>albicans</i></td></tr><tr><td><... | <table><tr><td>Storage time</td><td>Test organism exposed to (name of the test)</td><td>Staphylococcus aureus</td><td>Staphylococcus epidermidis</td><td>Micrococcus luteus</td><td>Corynebacterium jeikeium</td><td>Candida albicans</td></tr><tr><td>< 1 min</td><td>neutralizer in saline peptone water (neutralizer toxicity... | <table><tr><td>Test organism exposed to (name of the test)</td><td>Staphylococcus aureus</td><td>Staphylococcus epidermidis</td><td>Micrococcus luteus</td><td>Corynebacterium jeikeium</td><td>Candida albicans</td></tr><tr><td>antiseptic solution (material control test)</td><td>0*</td><td>0*</td><td>0*</td><td>0*</td><t... |
e6e0e23b696d989b45073f908b705b77c8be2ca03b3e171fde698ff0b6550374.png | complex | <table><tr><td>Samples</td><td>Number</td><td>Gender</td><td>Age</td><td>Mean age</td></tr><tr><td rowspan="2">Controls (<i>n</i> = 15)</td><td>7</td><td>Male</td><td>32–77</td><td>51.1 ± 15.3</td></tr><tr><td>8</td><td>Female</td><td>46–61</td><td>52.6 ± 4.9</td></tr><tr><td rowspan="2">Symptomat... | <table><tr><td>Samples</td><td>Number</td></tr><tr><td rowspan="2">Controls (n = 15)</td><td>7</td></tr><tr><td>8</td></tr><tr><td rowspan="2">Symptomatic HD (n = 16)</td><td>8</td></tr><tr><td>8</td></tr></table> | <table><tr><td>Gender</td><td>Age</td><td>Mean age</td></tr><tr><td>Male</td><td>32–77</td><td>51.1 ± 15.3</td></tr><tr><td>Female</td><td>46–61</td><td>52.6 ± 4.9</td></tr><tr><td>Male</td><td>48–65</td><td>60.6 ± 5.6</td></tr><tr><td>Female</td><td>46–67</td><td>55.2 ± 7.3</td></tr></table> |
7584b08123aa0daca04d1c4dfffe29b132dea2be37122d91e502045cae43e0f6.png | simple | <table><tr><td>Haplotype</td><td>case(frequency)</td><td>control(frequency)</td><td><i>P</i>-value</td><td>OR(95% CI)</td></tr><tr><td>C G G</td><td>323.66 (0.680)</td><td>852.26 (0.670)</td><td>0.745</td><td>1.039 [0.826~ 1.306]</td></tr><tr><td>G A A</td><td>103.66 (0.218)</td><td>324.60 (0.255)</td><td>0.099</td><td... | <table><tr><td>Haplotype</td><td>case(frequency)</td><td>control(frequency)</td><td>P-value</td><td>OR(95% CI)</td></tr><tr><td></td><td>3</td><td>85</td><td></td><td>1.039 [0.826~ 1.306</td></tr></table> | <table><tr><td>Haplotype</td><td>case(frequency)</td><td>control(frequency)</td><td>P-value</td><td>OR(95% CI)</td></tr><tr><td>C G G</td><td>23.66 (0.680)</td><td>2.26 (0.670)</td><td>0.745</td><td>]</td></tr><tr><td>G A A</td><td>103.66 (0.218)</td><td>324.60 (0.255)</td><td>0.099</td><td>0.809 [0.629~ 1.041]</td></t... |
57bdb587c82f5865aec8c1b9f177aaa42846a5c9d14a7c2af4d9b24c2bd403ab.png | simple | <table><tr><td>Age group</td><td>Number of patients with condylar changes</td></tr><tr><td>20–40 (Group A)</td><td>16 (64%)</td></tr><tr><td>41–60 (Group B)</td><td>22 (88%)</td></tr><tr><td>61 and above (Group C)</td><td>23 (92%)</td></tr></table> | <table><tr><td>Age group</td><td>Number of patients with condylar changes</td></tr></table> | <table><tr><td>20–40 (Group A)</td><td>16 (64%)</td></tr><tr><td>41–60 (Group B)</td><td>22 (88%)</td></tr><tr><td>61 and above (Group C)</td><td>23 (92%)</td></tr></table> |
913f014ffbea8633132e62f8cb31e809fbf402252ebcc101043ce535662d79a8.png | simple | <table><tr><td>MiRNA</td><td>Control</td><td>p16 Carriers</td><td><i>p</i> Value</td></tr><tr><td>hsa-let-7b</td><td>0.118 ± 0.001</td><td>0.104 ± 0.012</td><td>0.217</td></tr><tr><td>hsa-let-7g</td><td>0.056 ± 0.007</td><td>0.051 ± 0.011</td><td>0.350</td></tr><tr><td>hsa-miR-125b</td><td>1.319 ... | <table><tr><td>MiRNA</td><td>Control</td><td>p16 Carriers</td><td>p Value</td></tr><tr><td>hsa-let-7b</td><td>0.118 ± 0.001</td><td>0.104 ± 0.012</td><td>0.217</td></tr><tr><td>hsa-let-7g</td><td>0.056 ± 0.007</td><td>0.051 ± 0.011</td><td>0.350</td></tr><tr><td>hsa-miR-125b</td><td>1.319 ± 0.125</td><td>1.251 ± 0.150<... | <table><tr><td>MiRNA</td><td>Control</td><td>p16 Carriers</td><td>p Value</td></tr><tr><td>hsa-miR-199a</td><td>0.017 ± 0.004</td><td>0.016 ± 0.010</td><td>0.451</td></tr><tr><td>hsa-miR-19a</td><td>0.421 ± 0.067</td><td>0.409 ± 0.053</td><td>0.446</td></tr><tr><td>hsa-miR-19b</td><td>0.558 ± 0.090</td><td>0.543 ± 0.07... |
c45537c2c3bedf9f11d2887d9044aa5faa69c5acab8be8eaa708b5dab04afa8f.png | complex | <table><tr><td rowspan="2">Type of Intervention</td><td colspan="5">Overall mean blood : sweat ratio</td></tr><tr><td>BDE 28</td><td>BDE 47</td><td>BDE 99</td><td>BDE 100</td><td>BDE 153</td></tr><tr><td>Exercise (<i>n</i> = 3)</td><td>137.2</td><td>25.5</td><td>4.8</td><td>16.9</td><td>26.9</td></tr><tr><td>Infrared s... | <table><tr><td rowspan="2">Type of Intervention</td><td colspan="5">Overall mean blood : sweat ratio</td></tr><tr><td>BDE 28</td><td>BDE 47</td><td>BDE 99</td><td>BDE 100</td><td>BDE 153</td></tr><tr><td>Exercise (n = 3)</td><td>137.2</td><td>25.5</td><td>4.8</td><td>16.9</td><td>26.9</td></tr></table> | <table><tr><td>Infrared sauna (n = 8)</td><td>17.9</td><td>32.1</td><td>3.25</td><td>94.6</td><td>71.8</td></tr><tr><td>Steam sauna (n = 6)</td><td>69.5</td><td>26.3</td><td>5.6</td><td>2.4</td><td>121.2</td></tr></table> |
d77a85ad52899e59c0617fa6caf3ca52a34b520b5c9e2490e9c5c8a94e112c96.png | complex | <table><tr><td>Key barriers</td><td>Key facilitators</td></tr><tr><td>Capabilities: Stress associated with being an asylum seeker</td><td>Stress drove activity</td></tr><tr><td>Decision process: Living in limbo</td><td>Feeling settled and secure</td></tr><tr><td>Resources and environment Lack of money for food and equi... | <table><tr><td>Key barriers</td><td>Key facilitators</td></tr><tr><td>Capabilities: Stress associated with being an asylum seeker</td><td>Stress drove activity</td></tr><tr><td>Decision process: Living in limbo</td><td>Feeling settled and secure</td></tr><tr><td>Resources and environment Lack of money for food and equi... | <table><tr><td>Key barriers</td><td>Key facilitators</td></tr><tr><td colspan="2">Social</td></tr><tr><td>Exercising With friends/ family Alone in the UK Cultural influences</td><td>Exercising With friends/ family</td></tr><tr><td colspan="2">Knowledge and skills</td></tr><tr><td>The phrase ‘physical activity’ and reco... |
5b7631cf3e2000fff71b92af7118bc04eb1cb4e711e6543390d98fd71b75aa89.png | simple | <table><tr><td>Disease</td><td>miRNA</td><td>Expression level</td><td>Contributors</td></tr><tr><td>Breast cancer</td><td>miR-29a</td><td>Up-regulation</td><td>Wu et al., J Biomed Biotechnol. (2010) [76]</td></tr><tr><td> </td><td>miR-21</td><td> </td><td>Asaga et al., Clin Chem. (2011) [77]</td></tr><tr><td>Lung cance... | <table><tr><td>Disease</td><td>miRNA</td><td>Expression level</td><td>Contributors</td></tr><tr><td>Breast cancer</td><td>miR-29a</td><td>Up-regulation</td><td>Wu et al., J Biomed Biotechnol. (2010) [76]</td></tr><tr><td></td><td>miR</td><td></td><td></td></tr></table> | <table><tr><td>Disease</td><td>miRNA</td><td>Expression level</td><td>Contributors</td></tr><tr><td></td><td>-21</td><td></td><td>Asaga et al., Clin Chem. (2011) [77]</td></tr><tr><td>Lung cancer</td><td>miR-21,1254,574-5p</td><td>Up-regulation</td><td>Wei et al., Chin J Cancer. (2011) [79]</td></tr><tr><td></td><td></... |
584d3b6079e9b6e4799d9ec23a843aaeade7d4864fb1d17ef5f83699b2c0f3ff.png | simple | <table><tr><td>Categories</td><td>Cohorts (<i>n</i>)</td><td>HR (95%CI)</td><td><i>P</i> value</td><td><i>I</i><sup>2</sup> (%)</td><td>Model types</td></tr><tr><td>OS</td><td>8 (4448)</td><td>0.99 (0.77–1.27)</td><td>0.96</td><td>82</td><td>Random-effects</td></tr><tr><td>PFS</td><td>3 (2861)</td><td>1.26 (1.15&... | <table><tr><td>Categories</td><td>Cohorts (n)</td><td>HR (95%CI)</td><td>P value</td><td>I2 (%)</td><td>Model types</td></tr><tr><td>OS</td><td>8 (4448)</td><td>0.99 (0.77–1.27)</td><td>0.96</td><td>82</td><td>Random-effects</td></tr><tr><td>PFS</td><td>3 (2861)</td><td>1.26 (1.15–1.39)</td><td><0.00001</td><td>32</td>... | <table><tr><td>M65</td><td>3 (1546)</td><td>0.72 (0.61–0.86)</td><td>0.0003</td><td>0</td></tr></table> |
029f112876b2d917ab2dc89519be5bd9db4aa6829679bd428e34b713e8dd2835.png | complex | <table><tr><td></td><td>Total (<i>n</i>)</td><td>Always % (standard error)</td><td>Not in international competition</td><td>Not >10 fights</td><td>Other</td><td>Never</td></tr><tr><td>Total</td><td>431</td><td>71.5 (5.6)</td><td>7.2 (3.2)</td><td>10.7 (3.8)</td><td>4.9 (2.7)</td><td>5.8 (3.0)</td></tr><tr><td colspa... | <table><tr><td></td><td>Total (n)</td><td>Always % (standard error)</td><td>Not in international competition</td><td>Not >10 fights</td></tr><tr><td>Total</td><td>431</td><td>71.5 (5.6)</td><td>7.2 (3.2)</td><td>10.7 (3.8)</td></tr><tr><td colspan="5">Sex</td></tr><tr><td>Male</td><td>310</td><td>64.2 (6.9)</td><td>8.7... | <table><tr><td>Other</td><td>Never</td></tr><tr><td>4.9 (2.7)</td><td>5.8 (3.0)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>5.8 (3.5)</td><td>7.4 (3.9)</td></tr><tr><td>2.6 (4.5)</td><td>1.7 (4.0)</td></tr><tr><td>0 (28.5)</td><td>0 (28.5)</td></tr><tr><td colspan="2">Age</td></tr><tr><td>9.4 (13.9)</td><td>9.4 (... |
5e8f26ca629c797d09c5c289251edb3406337fdfb3c034f50eef8fdf5b218d6d.png | complex | <table><tr><td></td><td></td><td colspan="2">Southern zone</td><td colspan="2">Middle zone</td><td colspan="2">Northern zone</td></tr><tr><td>Indication</td><td>Medicine name</td><td>Before</td><td>After</td><td>Before</td><td>After</td><td>Before</td><td>After</td></tr><tr><td>Malaria</td><td>ACTs</td><td>53.80</td><t... | <table><tr><td></td><td></td><td colspan="2">Southern zone</td><td colspan="2">Middle zone</td><td colspan="2">Northern zone</td></tr><tr><td>Indication</td><td>Medicine name</td><td>Before</td><td>After</td><td>Before</td><td>After</td><td>Before</td><td>After</td></tr></table> | <table><tr><td>Malaria</td><td>ACTs</td><td>53.80</td><td>7.70</td><td>33.30</td><td>0</td><td>40.00</td><td>0</td></tr><tr><td>Asthma</td><td>Salbutamol</td><td>25.00</td><td>7.70</td><td>26.70</td><td>6.20</td><td>0</td><td>20.00</td></tr><tr><td>Diabetes</td><td>Gilbendamide</td><td>38.50</td><td>30.80</td><td>20.00... |
846cb1f5d3003853b518387e131b66f531c9cb51686ffafab5ba887b76636885.png | simple | <table><tr><td>Paper</td><td># of patients</td><td>Types of mutations</td></tr><tr><td>Bartsch et al 1997 [7]</td><td>1</td><td>Translocation</td></tr><tr><td>Matsumoto et al 1997 [6]</td><td>1</td><td>Deletion</td></tr><tr><td>Møller et al 2008 [8]</td><td>2</td><td>2 translocations</td></tr><tr><td>Fujita et al ... | <table><tr><td>Paper</td><td># of patients</td><td>Types of mutations</td></tr><tr><td>Bartsch et al 1997 [7]</td><td>1</td><td>Translocation</td></tr><tr><td>Matsumoto et al 1997 [6]</td><td>1</td><td>Deletion</td></tr><tr><td>Møller et al 2008 [8]</td><td>2</td><td>2 translocations</td></tr></table> | <table><tr><td>Fujita et al 2010 [9]</td><td>1</td><td>Deletion</td></tr><tr><td>Oegema et al 2010 [10]</td><td>2</td><td>2 deletions</td></tr><tr><td>Yamamoto et al 2011 [11]</td><td>3</td><td>3 deletions</td></tr><tr><td>van Bon et al 2011 [12]</td><td>1</td><td>Deletion</td></tr><tr><td>Valetto et al 2012 [13]</td><... |
8f2e462d4b51e805d6c29e56cd6367b837b47a3d375c6874c75d5886a52ead21.png | simple | <table><tr><td>Name</td><td>Origin</td><td>Sex</td><td>C14 Date (calibrated)</td><td>Endogenous (%)</td><td>Unique (%)</td><td>MT and Y haplogroup</td><td>Mean autosomal coverage</td></tr><tr><td>L</td><td>Linton</td><td>Female</td><td>360–50 BCE</td><td>72</td><td>54</td><td>H1e</td><td>1.4</td></tr><tr><td>HI1<... | <table><tr><td>Name</td><td>Origin</td><td>Sex</td><td>C14 Date (calibrated)</td><td>Endogenous (%)</td><td>Unique (%)</td><td>MT and Y haplogroup</td><td>Mean autosomal coverage</td></tr><tr><td>L</td><td>Linton</td><td>Female</td><td>360–50 BCE</td><td>72</td><td>54</td><td>H1e</td><td>1.4</td></tr><tr><td>HI1</td><t... | <table><tr><td>Name</td><td>Origin</td><td>Sex</td><td>C14 Date (calibrated)</td><td>Endogenous (%)</td><td>Unique (%)</td><td>MT and Y haplogroup</td><td>Mean autosomal coverage</td></tr><tr><td>HS3</td><td>Hinxton</td><td>Female</td><td>690–881 CE</td><td>16</td><td>71</td><td>H2a2a1</td><td>0.9</td></tr></table> |
969a66b2f39e00eeae5ed0acd6b78bd20291b10cd78a407c1c973cb5bd1efdfc.png | simple | <table><tr><td>Evaluation criteria</td><td>Medium range contacts</td><td>Long range contacts</td></tr><tr><td>Top L/5</td><td>.34 (.18)</td><td>.30 (.05)</td></tr><tr><td>Top L/5, δ = 1</td><td>.55 (.27)</td><td>.48 (.07)</td></tr><tr><td>Top L/5, δ = 2</td><td>.64 (.29)</td><td>.56 (.08)</td></tr></table> | <table><tr><td>Evaluation criteria</td><td>Medium range contacts</td><td>Long range contacts</td></tr><tr><td>Top L/5</td><td>.34 (.18)</td><td>.30 (.05)</td></tr><tr><td>Top L</td><td>.</td><td>.</td></tr></table> | <table><tr><td>/5, δ = 1</td><td>55 (.27)</td><td>48 (.07)</td></tr><tr><td>Top L/5, δ = 2</td><td>.64 (.29)</td><td>.56 (.08)</td></tr></table> |
348908255ef231154a776d363b43fa8ac46a8164020cb21af9c707a642151cc2.png | complex | <table><tr><td rowspan="2">MRSA outbreaks</td><td colspan="4">Number of days</td><td></td><td colspan="8">Validity</td></tr><tr><td>TP</td><td>FP</td><td>FN</td><td>TN</td><td></td><td>Se</td><td>(95% CI)</td><td>Sp</td><td>(95% CI)</td><td>PPV</td><td>(95% CI)</td><td>NPV</td><td>(95% CI)</td></tr><tr><td>All</td><td>... | <table><tr><td rowspan="2">MRSA outbreaks</td><td colspan="4">Number of days</td><td></td><td colspan="8">Validity</td></tr><tr><td>TP</td><td>FP</td><td>FN</td><td>TN</td><td></td><td>Se</td><td>(95% CI)</td><td>Sp</td><td>(95% CI)</td><td>PPV</td><td>(95% CI)</td><td>NPV</td><td>(95% CI)</td></tr><tr><td>All</td><td>... | <table><tr><td>General hospital and unknown location</td><td>6</td><td>11</td><td>25</td><td>756</td><td>19</td><td>(7–37)</td><td>99</td><td>(97–99)</td><td>35</td><td>(18–58)</td><td>97</td><td>(96–97)</td></tr><tr><td>Nursing home</td><td>1</td><td>15</td><td>6</td><td>778</td><td>13</td><td>(0–53)</td><td>98</td><t... |
e4d626150dea5c0b5929f62a8bcae05b4dce6b905ec2075a82e236378563f4f0.png | complex | <table><tr><td> </td><td> </td><td>Mean fold change</td><td>Upper limit C.I</td><td>Lower limit C.I</td></tr><tr><td rowspan="2">AHPC</td><td>Overexpressed in virulent strains compared to the avirulent ATCC 33658 T</td><td> </td><td> </td><td> </td></tr><tr><td>Transcription Ratio of AHPC in the virulent strains compar... | <table><tr><td></td><td></td><td>Mean fold change</td><td>Upper limit C.I</td><td>Lower limit C.I</td></tr><tr><td rowspan="2">AHPC</td><td>Overexpressed in virulent strains compared to the avirulent ATCC 33658 T</td><td></td><td></td><td></td></tr><tr><td>Transcription Ratio of AHPC in the virulent strains compared to... | <table><tr><td>Transcription Ratio of the iron-poor cultures compared to the iron-rich ones:</td><td>3.65E + 01</td><td>5.14E + 01</td><td>2.64E + 01</td></tr></table> |
a392fb70296f762dc67e14d63abdb4f27eb6cb69c8c5a47de459d457907a28ee.png | complex | <table><tr><td>Years of formal education</td><td>Frequency (% out of n=43)</td><td>Frequency of Cognitive Dysfunction (%)</td><td>Frequency of normal Cognition (%)</td><td>Chi-square (x<sup>2</sup>) test</td><td>p-value</td></tr><tr><td>More than 12 years</td><td>16 (37.2)</td><td>8 (50.0)</td><td>8 (50.0)</td><td rows... | <table><tr><td>Years of formal education</td><td>Frequency (% out of n=43)</td><td>Frequency of Cognitive Dysfunction (%)</td><td>Frequency of normal Cognition (%)</td><td>Chi-square (x2) test</td><td>p-value</td></tr><tr><td>More than 12 years</td><td>16 (37.2)</td><td>8 (50.0)</td><td>8 (50.0)</td><td>2.563</td><td>0... | <table><tr><td>Years of formal education</td><td>Frequency (% out of n=43)</td><td>Frequency of Cognitive Dysfunction (%)</td><td>Frequency of normal Cognition (%)</td><td>Chi-square (x2) test</td><td>p-value</td></tr><tr><td>Less than 12 years</td><td>27 (62.8)</td><td>20 (74.1)</td><td>7 (25.9)</td><td>2.563</td><td>... |
41925d42ee62f9dfba3d8b421e5707d6afd19c0156b4315626e6a9cdb74620ab.png | simple | <table><tr><td>Type/site of TB</td><td>HIV-TB group</td></tr><tr><td>PTB [<i>n</i>(%)]</td><td>25 (20)*</td></tr><tr><td>EPTB [<i>n</i>(%)]</td><td>98 (80)</td></tr><tr><td>DTB [<i>n</i>(%)]</td><td>39 (32)</td></tr><tr><td>Lung + Pleura + mediastinal LN [<i>n</i>(%)]</td><td>11 (9)*</td></tr><tr><td>Pleura + RP/mesent... | <table><tr><td>Type/site of TB</td><td>HIV-TB group</td></tr><tr><td>PTB [n(%)]</td><td>25 (20)*</td></tr><tr><td>EPTB [n(%)]</td><td>98 (80)</td></tr><tr><td>DTB [n(%)]</td><td>39 (32)</td></tr><tr><td>Lung + Pleura + mediastinal LN [n(%)]</td><td>11 (9)*</td></tr><tr><td>Pleura + RP/mesenteric LN [n(%)]</td><td>6 (5)... | <table><tr><td>Type/site of TB</td><td>HIV-TB group</td></tr><tr><td>Lymph node [n(%)]</td><td>16 (13)</td></tr><tr><td>Cervical [n(%)]</td><td>10 (8)†</td></tr><tr><td>Abdominal [n(%)]</td><td>4 (3)</td></tr><tr><td>RP + mesenteric LN</td><td>2 (2)</td></tr><tr><td>RP LN</td><td>1 (1)</td></tr><tr><td>Periportal + mes... |
5e3aea724c51e91ad09f206c88f25096d659965e247063ca61b42cce466caeba.png | complex | <table><tr><td><i>Dataset type</i></td><td colspan="3"><i>Control dataset</i></td><td colspan="3"><i>Real sample dataset</i></td></tr><tr><td>Dataset Name</td><td>D1</td><td>D2</td><td>D3</td><td>D4</td><td>D5</td><td>D6</td></tr><tr><td>Instrument</td><td>LCQ</td><td>LTQ</td><td>LTQ/FT</td><td>LCQ</td><td>LTQ</td><td>... | <table><tr><td>Dataset type</td><td colspan="3">Control dataset</td><td colspan="3">Real sample dataset</td></tr></table> | <table><tr><td>Dataset Name</td><td>D1</td><td>D2</td><td>D3</td><td>D4</td><td>D5</td><td>D6</td></tr><tr><td>Instrument</td><td>LCQ</td><td>LTQ</td><td>LTQ/FT</td><td>LCQ</td><td>LTQ</td><td>LTQ/FT</td></tr><tr><td>Reference or notes</td><td>[46]</td><td>[55]</td><td>unpublished</td><td>[44]</td><td>[56]</td><td>unpu... |
e067e4beca43e1975b16e7210897953a35cd8d6a7d552adb4426bbd2f206eea0.png | simple | <table><tr><td>Group</td><td>N (Male/Female)</td><td>Maternal Age (Years)</td><td>Maternal BMI before Pregnancy</td><td>Gestational Age (Weeks)</td><td>Birth Weight (g)</td><td>Body Length (cm)</td><td>Ponderal Index (kg/m<sup>3</sup>)</td><td>Head Circumference (cm)</td><td>Placenta Weight (g)</td></tr><tr><td>NBW</td... | <table><tr><td>Group</td><td>N (Male/Female)</td><td>Maternal Age (Years)</td><td>Maternal BMI before Pregnancy</td><td>Gestational Age (Weeks)</td><td>Birth Weight (g)</td><td>Body Length (cm)</td><td>Ponderal Index (kg/m3)</td><td>Head Circumference (cm)</td><td>Placenta Weight (g)</td></tr><tr><td>NBW</td><td>12 (6/... | <table><tr><td>W</td><td>6)</td><td>4</td><td>2.9</td><td>8.9 ± 0.9</td><td>7</td><td>.6</td><td>2 ± 5.2</td><td></td><td>± 38.5</td></tr><tr><td>p value</td><td>-</td><td>0.76</td><td>0.82</td><td>0.58</td><td><0.01 **</td><td>0.34</td><td>0.02 *</td><td>0.013 *</td><td><0.01 **</td></tr></table> |
168db7e8376fedfcb07cde5a7b9c99ecceca99ff8478eb3edefacd0eb578d5b8.png | complex | <table><tr><td>Result/PCR target positivity</td><td>Interpretation/meaning</td><td>Action</td></tr><tr><td>G3PD 567 bp (+)</td><td rowspan="3">Valid results for parasite diagnosis</td><td rowspan="3">Conclude diagnostic test observation</td></tr><tr><td>pUC 316 bp (+)</td></tr><tr><td><i>L. braziliensis </i>138 bp (+)<... | <table><tr><td>Result/PCR target positivity</td><td>Interpretation/meaning</td><td>Action</td></tr><tr><td>G3PD 567 bp (+)</td><td rowspan="3">Valid results for parasite diagnosis</td><td rowspan="3">Conclude diagnostic test observation</td></tr><tr><td>pUC 316 bp (+)</td></tr><tr><td>L. braziliensis 138 bp (+)</td></t... | <table><tr><td>Result/PCR target positivity</td><td>Interpretation/meaning</td><td>Action</td></tr><tr><td>G3PD 567 bp (+)</td><td rowspan="3">Valid results for parasite diagnosis despite small loss of DNA in extraction</td><td rowspan="3">Conclude diagnostic test observation</td></tr><tr><td>pUC 316 bp (-)</td></tr><t... |
e0d684fa992ff298402b09b723e24dbabf864779eefa164ea0a444d0df324e09.png | complex | <table><tr><td colspan="2">Microtiter plate [28]</td><td colspan="2">Microtiter plate [29]</td><td colspan="2">RISE [30]</td></tr><tr><td colspan="2">Round 1 (h)</td><td colspan="2">Round 1 (h)</td><td colspan="2">Round 1 (h)</td></tr><tr><td>Target incubation</td><td>18</td><td>Target incubation</td><td>2</td><td>Targ... | <table><tr><td colspan="2">Microtiter plate [28]</td></tr><tr><td colspan="2">Round 1 (h)</td></tr><tr><td>Target incubation</td><td>18</td></tr><tr><td>Wash-postcoat</td><td>2.25</td></tr><tr><td>Phage incubation</td><td>1</td></tr><tr><td>Wash-elution</td><td>0.5</td></tr><tr><td>Infection</td><td></td></tr><tr><td>-... | <table><tr><td colspan="2">Microtiter plate [29]</td><td colspan="2">RISE [30]</td></tr><tr><td colspan="2">Round 1 (h)</td><td colspan="2">Round 1 (h)</td></tr><tr><td>Target incubation</td><td>2</td><td>Target incubation</td><td>18</td></tr><tr><td>Wash-postcoat</td><td>1.5</td><td>Wash-postcoat</td><td>4</td></tr><t... |
6b25f1c7cdf6c06831f15450abfecca20876b090f531da5eed60e2cd23bf115e.png | complex | <table><tr><td rowspan="2"></td><td colspan="10">Group</td></tr><tr><td rowspan="3">Variables</td><td colspan="2">G1: Nordic walking (N=8)</td><td rowspan="3"><i>p</i><sup>a</sup></td><td colspan="2">G2: Water aerobics (N=8)</td><td rowspan="3"><i>p</i><sup>a</sup></td><td colspan="2">G3: Non-exercising (N=8)</td><td r... | <table><tr><td rowspan="2"></td><td colspan="10">Group</td><td></td></tr><tr><td rowspan="3">Variables</td><td colspan="2">G1: Nordic walking (N=8)</td><td rowspan="3">pa</td><td colspan="2">G2: Water aerobics (N=8)</td><td rowspan="3">pa</td><td colspan="2">G3: Non-exercising (N=8)</td><td rowspan="3">pa</td><td rowsp... | <table><tr><td rowspan="2"></td><td colspan="10">Group</td></tr><tr><td rowspan="3">Variables</td><td colspan="2">G1: Nordic walking (N=8)</td><td rowspan="3">pa</td><td colspan="2">G2: Water aerobics (N=8)</td><td rowspan="3">pa</td><td colspan="2">G3: Non-exercising (N=8)</td><td rowspan="3">pa</td></tr><tr><td>Basel... |
469ae084f65d779eab28d4fc99950e6123368838e60d6d4d5a3de828ae208b6f.png | simple | <table><tr><td>Time Series</td><td>Germ layer</td><td>TP#</td><td>Switching#</td><td>Gene#</td><td>%</td><td>Non-Xover</td><td>%</td><td>Xover</td><td>%</td></tr><tr><td>Cerebellar development</td><td>Ectoderm</td><td>12</td><td>48,489</td><td>5433</td><td>21.6</td><td>38,722</td><td>79.9</td><td>9767</td><td>20.1</td>... | <table><tr><td>Time Series</td><td>Germ layer</td><td>TP#</td><td>Switching#</td><td>Gene#</td><td>%</td><td>Non-Xover</td><td>%</td><td>Xover</td><td>%</td></tr><tr><td>Cerebellar development</td><td>Ectoderm</td><td>12</td><td>48,489</td><td>5433</td><td>21.6</td><td>38,722</td><td>79.9</td><td>9767</td><td>20.1</td>... | <table><tr><td>Time Series</td><td>Germ layer</td><td>TP#</td><td>Switching#</td><td>Gene#</td><td>%</td><td>Non-Xover</td><td>%</td><td>Xover</td><td>%</td></tr><tr><td>13</td><td>esoderm</td><td></td><td>25</td><td>7</td><td></td><td>4</td><td>68.4</td><td></td><td>31.6</td></tr><tr><td>AoSMC response to IL1b</td><td... |
d873417b3ead39b1aa6b0d07051d30d1bcb258ae2efad73f619e7a035260305b.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>Hazard ratio</td><td>Confidence interval</td><td><i>p</i>-value</td><td>Hazard ratio</td><td>Confidence interval</td><td><i>p</i>-value</td></tr><tr><td>NKp30, C1D1, LFS</td><td>0.24</t... | <table><tr><td rowspan="2">Variable</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>Hazard ratio</td><td>Confidence interval</td><td>p-value</td><td>Hazard ratio</td><td>Confidence interval</td><td>p-value</td></tr><tr><td>NKp30, C1D1, LFS</td><td>0.24</td><td>0.099–0.... | <table><tr><td rowspan="2">Variable</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>Hazard ratio</td><td>Confidence interval</td><td>p-value</td><td>Hazard ratio</td><td>Confidence interval</td><td>p-value</td></tr><tr><td>NKp46, C1D21, LFS</td><td>0.25</td><td>0.10–0.... |
01050a54ad4f06308694376d5de3ff399293ce5368af44a401c885c4044ac527.png | simple | <table><tr><td>Number</td><td>Data Source</td><td>Age/years</td><td>Professional background</td></tr><tr><td>1</td><td>Focus group</td><td>53</td><td>Bereavement counselor</td></tr><tr><td>2</td><td>Focus group</td><td>39</td><td>Communication consultant</td></tr><tr><td>3</td><td>Focus group</td><td>46</td><td>Directo... | <table><tr><td>Number</td><td>Data Source</td><td>Age/years</td><td>Professional background</td></tr><tr><td>1</td><td>Focus group</td><td>53</td><td>Bereavement counselor</td></tr><tr><td>2</td><td>Focus group</td><td>39</td><td>Communication consultant</td></tr><tr><td>3</td><td>Focus group</td><td>46</td><td>Directo... | <table><tr><td>Number</td><td>Data Source</td><td>Age/years</td><td>Professional background</td></tr><tr><td>8</td><td>Assignment</td><td>55</td><td>Facilitator in development sector</td></tr><tr><td>9</td><td>Assignment</td><td>55</td><td>Physiotherapist</td></tr><tr><td>10</td><td>Assignment</td><td>69</td><td>Counse... |
e70fba0d20246b245a046a5f3456bc2d2f6f5aef7f4b90a0bd8aab97c01c3bbf.png | simple | <table><tr><td>Characteristic</td><td>Training set</td><td>Testing set</td><td>Total</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td> Median</td><td>59</td><td>58</td><td>59</td></tr><tr><td> Range</td><td>38∼85</td><td>30∼87</td><td>30∼87</td></tr><tr><td>Clinical stage</td><td></td>... | <table><tr><td>Characteristic</td><td>Training set</td><td>Testing set</td><td>Total</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td>Median</td><td>59</td><td>58</td><td>59</td></tr><tr><td>Range</td><td>38∼85</td><td>30∼87</td><td>30∼87</td></tr><tr><td>Clinical stage</td><td></td><td></td><td></td></... | <table><tr><td>Characteristic</td><td>Training set</td><td>Testing set</td><td>Total</td></tr><tr><td>Living</td><td>91</td><td>88</td><td>179</td></tr><tr><td>Dead</td><td>112</td><td>116</td><td>228</td></tr></table> |
d1c3c36dc9da54d39f3d910b5568cbf349d12149f3ce6c206f04de266ed5d41b.png | simple | <table><tr><td> </td><td>All cases (n)</td><td>Fatality (n)</td><td>CFR(95%CI) (%)</td><td>RSE (%)</td></tr><tr><td>Pre-intervention period</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>(Eclampsia patients)</td><td>1233</td><td>258</td><td>20.9(18.7, 23.2)</td><td>5.5</td></tr><tr><td>Intervention period</td... | <table><tr><td></td><td>All cases (n)</td><td>Fatality (n)</td><td>CFR(95%CI) (%)</td><td>RSE (%)</td></tr></table> | <table><tr><td>Pre-intervention period</td><td></td><td></td><td></td><td></td></tr><tr><td>(Eclampsia patients)</td><td>1233</td><td>258</td><td>20.9(18.7, 23.2)</td><td>5.5</td></tr><tr><td>Intervention period</td><td></td><td></td><td></td><td></td></tr><tr><td>(Eclampsia patients)</td><td>996</td><td>23</td><td>2.3... |
1a71b69116330ec571a50f0fdb2545b7aee004a9e1aba2cd552665d43182243b.png | simple | <table><tr><td>Certified Reference Materials</td><td>DON Immunosensor (ppm)</td><td>ELISA (ppm)</td><td>Vendor (ppm)</td></tr><tr><td>Wheat</td><td>0.3</td><td>0.2</td><td>0.71</td></tr><tr><td>Corn</td><td>0.92</td><td>1.1</td><td>1.88</td></tr><tr><td>Roasted coffee</td><td>0.19</td><td>0.24</td><td>0.77</td></tr></t... | <table><tr><td>Certified Reference Materials</td><td>DON Immunosensor (ppm)</td><td>ELISA (ppm)</td><td>Vendor (ppm)</td></tr></table> | <table><tr><td>Wheat</td><td>0.3</td><td>0.2</td><td>0.71</td></tr><tr><td>Corn</td><td>0.92</td><td>1.1</td><td>1.88</td></tr><tr><td>Roasted coffee</td><td>0.19</td><td>0.24</td><td>0.77</td></tr></table> |
348affe26dfd0ee8fd517bb2c8c9b3d1edda2164203494f7b9df62853307e5ce.png | complex | <table><tr><td rowspan="2">Genetic comparison</td><td rowspan="2">Overall and subgroup analysis</td><td rowspan="2">No. of studies</td><td colspan="2">Heterogeneity</td><td rowspan="2">Model</td><td colspan="2">Meta-analysis</td></tr><tr><td>p</td><td><i>I</i><sup>2</sup>(%)</td><td>OR(95%CI)</td><td>p</td></tr><tr><td... | <table><tr><td rowspan="2">Genetic comparison</td><td rowspan="2">Overall and subgroup analysis</td><td rowspan="2">No. of studies</td><td colspan="2">Heterogeneity</td><td rowspan="2">Model</td><td colspan="2">Meta-analysis</td></tr><tr><td>p</td><td>I2(%)</td><td>OR(95%CI)</td><td>p</td></tr><tr><td>T vs. C</td><td>O... | <table><tr><td rowspan="2">Genetic comparison</td><td rowspan="2">Overall and subgroup analysis</td><td rowspan="2">No. of studies</td><td colspan="2">Heterogeneity</td><td rowspan="2">Model</td><td colspan="2">Meta-analysis</td></tr><tr><td>p</td><td>I2(%)</td><td>OR(95%CI)</td><td>p</td></tr><tr><td></td><td>CP</td><... |
e52b4fa8a78e0579a9943764fce6ca32ccf79104cf273baecdd47a22213bdfa4.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Confidence ratings at end of module (N≥294)</td><td colspan="2">Confidence ratings 3–6 Months after completion (N≥106)</td></tr><tr><td>Mean<sup>1</sup></td><td>%<sup>2</sup></td><td>Mean<sup>1</sup></td><td>%<sup>2</sup></td></tr><tr><td>RespondentR... | <table><tr><td rowspan="2"></td><td colspan="2">Confidence ratings at end of module (N≥294)</td><td colspan="2">Confidence ratings 3–6 Months after completion (N≥106)</td></tr><tr><td>Mean1</td><td>%2</td><td>Mean1</td><td>%2</td></tr><tr><td>Respondent’s Confidence in his or her ability to:</td><td></td><td></td><td><... | <table><tr><td colspan="5">Respondent’s confidence in her or his knowledge/awareness of:</td></tr><tr><td>(a) non-pharmacological interventions (cognitive behavioral skills such as activation, relaxation, negative thinking)</td><td>1.90</td><td>86.8</td><td>1.76</td><td>91.7</td></tr><tr><td>(b) regional mental health ... |
c180297af1bebbffd210c0a0dc496422cb4894be95afa4cb77e255eb187a47ea.png | simple | <table><tr><td>Reaction</td><td>Genes</td><td>Primer names</td><td>Forward primer sequence</td><td>Reverse primer sequence</td><td>Size (bp)</td></tr><tr><td></td><td><i>hsp60 </i>(groEL_1)</td><td>hsp3/hsp4</td><td>GACCGCCAGTTAAGATAGCG</td><td>TCTCTAGCTACTTCGCAACAAATCC</td><td>297</td></tr><tr><td>1</td><td>CTL0626</t... | <table><tr><td>Reaction</td><td>Genes</td><td>Primer names</td><td>Forward primer sequence</td><td>Reverse primer sequence</td><td>Size (bp)</td></tr><tr><td></td><td>hsp60 (groEL_</td><td>hsp3</td><td>GACCGCCAGTTAAGAT</td><td>TCTC</td><td>297</td></tr></table> | <table><tr><td></td><td>1)</td><td>/hsp4</td><td>AGCG</td><td>TAGCTACTTCGCAACAAATCC</td><td></td></tr><tr><td>1</td><td>CTL0626</td><td>CTL06265'F/CTL06265'R</td><td>GCACACCATCACTATCAC</td><td>GCGCTTGCTTGAGATTTC</td><td>226</td></tr><tr><td>2</td><td>CTL0627</td><td>CTL06275'F/CTL06275'R</td><td>GTTGGCGAGTCCGATGATG</td... |
c63606829cd22c3a823a105695f400e0582200039eb132ca9cae7a96f3a60561.png | simple | <table><tr><td>Impact factors</td><td><i>P</i>-value</td><td>Impact factors</td><td><i>P</i>-value</td></tr><tr><td>Epidemiologic information</td><td></td><td>Chemotherapy detail</td><td></td></tr><tr><td>Age at diagnosis</td><td>0.335</td><td>PEB/PVB</td><td>0.043</td></tr><tr><td>Ethnic group</td><td>0.856</td><td>Bl... | <table><tr><td>Impact factors</td><td>P-value</td><td>Impact factors</td><td>P-value</td></tr><tr><td>Epidemiologic information</td><td></td><td>Chemotherapy detail</td><td></td></tr><tr><td>Age at diagnosis</td><td>0.335</td><td>PEB/PVB</td><td>0.043</td></tr><tr><td>Ethnic group</td><td>0.856</td><td>Bleomycin/pingya... | <table><tr><td>Drug allergy</td><td>2</td><td>rocyte</td><td>.116</td></tr><tr><td>Granulopenia</td><td>0.176</td><td>Thrombocyte</td><td>0.035</td></tr><tr><td>Anemia</td><td>0.041</td><td>Chalybeate</td><td>0.067</td></tr><tr><td>Thrombocytopenia</td><td>0.000</td><td>Post-chemotherapy surgery</td><td>0.072</td></tr>... |
f98340786ad83fd873511812107c3fa770b58fdeec10057025cacc4e077f6561.png | simple | <table><tr><td>>Stage of development</td><td>>WT versus AS</td><td>>WT versus OE</td></tr><tr><td>Immature green</td><td>234</td><td>333</td></tr><tr><td>Mature green</td><td>68</td><td>112</td></tr><tr><td>Red ripe</td><td>105</td><td>332</td></tr><tr><td>Total</td><td>407</td><td>777</td></tr></table> | <table><tr><td>>Stage of development</td><td>>WT versus AS</td><td>>WT versus OE</td></tr><tr><td>Immature green</td><td>234</td><td>333</td></tr><tr><td>Mature green</td><td>68</td><td>112</td></tr><tr><td>Red ripe</td><td>105</td><td>332</td></tr></table> | <table><tr><td>Total</td><td>407</td><td>777</td></tr></table> |
8fe792290d4fd43a0fe5417a37522e94475b59aab3cd821d16875a5d9e9ecbee.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">All digital ulcers</td><td colspan="3">Fingertip digital ulcers</td><td colspan="3">Extensor digital ulcers</td></tr><tr><td>GTN</td><td>PBO</td><td>Comparison</td><td>GTN</td><td>PBO</td><td>Comparison</td><td>GTN</td><td>PBO</td><td>Comparison</td></tr><tr><td colspan="... | <table><tr><td rowspan="2"></td><td colspan="3">All digital ulcers</td><td>Fingertip digital ulcers</td></tr><tr><td>GTN</td><td>PBO</td><td>Comparison</td><td>GTN</td></tr><tr><td colspan="5">DUCore</td></tr><tr><td>AUC (arbitrary perfusion units)</td><td>26,245.42 (19,829.5)</td><td>23,973.97 (18,607.44)</td><td>1.2 ... | <table><tr><td colspan="2">Fingertip digital ulcers</td><td colspan="3">Extensor digital ulcers</td></tr><tr><td>PBO</td><td>Comparison</td><td>GTN</td><td>PBO</td><td>Comparison</td></tr><tr><td colspan="5">DUCore</td></tr><tr><td>16,506.8 (12,498.3)</td><td>1.3 (0.7 to 2.2)</td><td>32,924.1 (24,038.9)</td><td>29,574.... |
a3f379eb37d52fc50f105aa6918da068b00f70009222196696e1b21abe3fa7b1.png | simple | <table><tr><td>No.</td><td>shRNA Targets of <i>RB1</i></td></tr><tr><td>siRNA-RB1-2</td><td>GGGUUGUGUCGAAAUUGGATT</td></tr><tr><td>siRNA-RB1-4</td><td>GGAGUAUGAUUCUAUUAUATT</td></tr><tr><td>Negative control siRNA (NC siRNA)</td><td>UUCUCCGAACGUGUCACGUTT</td></tr></table> | <table><tr><td>No.</td><td>shRNA Targets of RB1</td></tr><tr><td>siRNA-RB1-2</td><td>GGGUUGUGUCGAAAUUGGATT</td></tr><tr><td>s</td><td>GGAGUAU</td></tr></table> | <table><tr><td>No.</td><td>shRNA Targets of RB1</td></tr><tr><td>iRNA-RB1-4</td><td>GAUUCUAUUAUATT</td></tr><tr><td>Negative control siRNA (NC siRNA)</td><td>UUCUCCGAACGUGUCACGUTT</td></tr></table> |
3b1e3cb3acafeff44163cec372af81e4755643a39e1e2349c9b2050e9d6dea42.png | complex | <table><tr><td colspan="2">Module I: Basic concepts in global health</td></tr><tr><td>01.</td><td>Defining and measuring global health</td></tr><tr><td>02.</td><td>Global health definitions, case studies</td></tr><tr><td>03.</td><td>Historical origin and evolution</td></tr><tr><td>04.</td><td>Health systems and global ... | <table><tr><td colspan="2">Module I: Basic concepts in global health</td></tr><tr><td>01.</td><td>Defining and measuring global health</td></tr><tr><td>02.</td><td>Global health definitions, case studies</td></tr><tr><td>03.</td><td>Historical origin and evolution</td></tr><tr><td>04.</td><td>Health systems and global ... | <table><tr><td colspan="2">Module I: Basic concepts in global health</td></tr><tr><td>02.</td><td>Global health actors and activities</td></tr><tr><td>03.</td><td>Global health financing</td></tr><tr><td>04.</td><td>Global health policy and governance</td></tr><tr><td>05.</td><td>Drivers of policy for global health dip... |
a20bfab51027eaab7afca3978d9d1449b587136a636bf4123544814cb6de891b.png | simple | <table><tr><td>Questions</td><td>Partners</td><td>Regenstrief</td><td>Intermountain Health Care</td><td>Veterans' Health Administration</td></tr><tr><td>CIS modules offered (products that have capability to provide decision support)?</td><td>Yes, CPOE, results review, laboratory, outpatient clinical documentation, eMAR... | <table><tr><td>Questions</td><td>Partners</td><td>Regenstrief</td><td>Intermountain Health Care</td><td>Veterans' Health Administration</td></tr><tr><td>CIS modules offered (products that have capability to provide decision support)?</td><td>Yes, CPOE, results review, laboratory, outpatient clinical documentation, eMAR... | <table><tr><td>Content mgmt system separate from EHR?</td><td>Yes</td><td>No</td><td>Online K repository, most review/updates programmers</td><td>No. Pilots are ongoing.</td></tr><tr><td>Reporting capability to track effect/usage of CDS content?</td><td>Yes</td><td>User responses prospectively, not retrospective</td><t... |
e9841c6672802eed33bd5aabf725107fbd0581ecd018bafee085705d640055d3.png | simple | <table><tr><td></td><td>NZ</td><td>BL</td><td>SY</td><td>BK</td><td>WL†</td><td>EB†</td></tr><tr><td>NZ</td><td>-</td><td>0.030</td><td><underline>0.001</underline></td><td><underline>0.015</underline></td><td>0.074</td><td>0.096</td></tr><tr><td>BL</td><td>0.014</td><td>-</td><td>0.038</td><td>0.030</td><t... | <table><tr><td></td><td>NZ</td><td>BL</td><td>SY</td><td>BK</td><td>WL†</td><td>EB†</td></tr><tr><td>NZ</td><td>-</td><td>0.030</td><td>0.001</td><td>0.015</td><td>0.074</td><td>0.096</td></tr><tr><td>BL</td><td>0.014</td><td>-</td><td>0.038</td><td>0.030</td><td>0.061</td><td>0.104</td></tr><tr><td>SY</td><td>0.042</t... | <table><tr><td></td><td>NZ</td><td>BL</td><td>SY</td><td>BK</td><td>WL†</td><td>EB†</td></tr><tr><td>K</td><td>0.038</td><td>070</td><td>0.033</td><td></td><td>096</td><td>11</td></tr><tr><td>WL†</td><td>0.048</td><td>0.047</td><td>0.079</td><td>0.080</td><td>-</td><td>0.033</td></tr><tr><td>EB†</td><td>0.078</td><td>0... |
4332318ebeb1851f7015308d05307ba5602b5f8b2522a3037b8f3b57be165298.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">H3K27me3</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>Low</td><td>High</td><td>Total</td></tr><tr><td>pS9-GSK3β</td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>13</td><td>10</td><td>23</td><td></td></tr><tr><td> High</td><td>23</td><td>64</td... | <table><tr><td rowspan="2"></td><td colspan="3">H3K27me3</td><td rowspan="2">P</td></tr><tr><td>Lo</td><td>High</td><td></td></tr></table> | <table><tr><td></td><td>w</td><td></td><td>Total</td><td> value</td></tr><tr><td>pS9-GSK3β</td><td></td><td></td><td></td><td></td></tr><tr><td>Low</td><td>13</td><td>10</td><td>23</td><td></td></tr><tr><td>High</td><td>23</td><td>64</td><td>87</td><td></td></tr><tr><td>Total</td><td>36</td><td>74</td><td>110</td><td><... |
74f53837c5b37eaf502dc6eb580051e1a8fc28a4a65c8bb29c46fa6fd89b5290.png | complex | <table><tr><td></td><td></td><td colspan="2">AS Genome</td><td colspan="2">AM Genome</td></tr><tr><td>Chromosome</td><td>Length, bp</td><td>Change (SNPs)</td><td>Change Rate</td><td>Change (SNPs)</td><td>Change Rate</td></tr><tr><td>1</td><td>66,776,104</td><td>391</td><td>170,783</td><td>404</td><td>165,287</td></tr><... | <table><tr><td></td><td></td><td colspan="2">AS Genome</td><td colspan="2">AM Genome</td></tr></table> | <table><tr><td>Chromosome</td><td>Length, bp</td><td>Change (SNPs)</td><td>Change Rate</td><td>Change (SNPs)</td><td>Change Rate</td></tr><tr><td>1</td><td>66,776,104</td><td>391</td><td>170,783</td><td>404</td><td>165,287</td></tr><tr><td>2</td><td>44,510,304</td><td>258</td><td>172,521</td><td>250</td><td>178,041</td... |
b4bb280ac8e0bb558aff942a4fb63bf665604f42342d5470938ca990c8fc4203.png | simple | <table><tr><td></td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Waist Circumference (abnormal versus normal)</td><td>1.697 (1.305–2.207)</td><td>1.712 (1.308–2.242)</td><td>1.40 (1.02–1.91)</td></tr><tr><td>Body Mass Index (abnormal versus normal)</td><td>1.901 (1.347–2.680)</td... | <table><tr><td></td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Waist Circumference (abnormal versus normal)</td><td>1.697 (1.305–2.207)</td><td>1.712 (1.308–2.242)</td><td>1.40 (1.02–1.91)</td></tr><tr><td>Body Mass Index (abnormal versus normal)</td><td>1.901 (1.347–2.680)</td><td>1.941 (1.367–2.754)... | <table><tr><td></td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Muscle Mass Index (abnormal versus normal)</td><td>1.113 (0.788–1.572)</td><td>1.190 (0.836–1.692)</td><td>1.42 (0.90–2.07)</td></tr></table> |
130654ee2ce5f8dd34a36fc2c864cbef2f6b879b2f238de4e61c7834939af364.png | simple | <table><tr><td>Humans and Great Apes</td><td>All other mammals e.g. mouse</td><td>Peptide abbreviation</td><td>Gene name</td></tr><tr><td>Relaxin-1</td><td>Relaxin<sup>#</sup></td><td>RLX1</td><td><i>RLN1</i></td></tr><tr><td>Relaxin-2<sup>#</sup></td><td></td><td>RLX2</td><td><i>RLN2</i></td></tr><tr><td>Relaxin-3</td... | <table><tr><td>Humans and Great Apes</td><td>All other mammals e.g. mouse</td><td>Peptide abbreviation</td><td>Gene name</td></tr><tr><td>Relaxin-1</td><td>Relaxin#</td><td>RLX1</td><td>RLN1</td></tr></table> | <table><tr><td>Relaxin-2#</td><td></td><td>RLX2</td><td>RLN2</td></tr><tr><td>Relaxin-3</td><td>Relaxin-3</td><td>RLX3</td><td>RLN3</td></tr></table> |
87ec1cbf7e8ac1ddb816e52e0c41066a642ec5e8e7f93c3b30290ff6b6cea2a5.png | simple | <table><tr><td>Identifier</td><td>Best Arabidopsis match</td><td>Possible function</td><td>Position (kb)</td><td>Gene ID</td></tr><tr><td><i>C2H2 TF</i></td><td>AT3G18290</td><td>RING finger and CHY zinc finger encoding BRUTUS (BTS), E3 ligase protein with metal ion binding and DNA binding domains, which negatively reg... | <table><tr><td>Identifier</td><td>Best Arabidopsis match</td><td>Possible function</td><td>Position (kb)</td><td>Gene ID</td></tr></table> | <table><tr><td>C2H2 TF</td><td>AT3G18290</td><td>RING finger and CHY zinc finger encoding BRUTUS (BTS), E3 ligase protein with metal ion binding and DNA binding domains, which negatively regulates the response to iron deficiency</td><td>1,000</td><td>MDP0000283750</td></tr><tr><td>C2H2 TF</td><td>AT1G68360</td><td>C2H2... |
241558ba26f216d6c6e32bea434f27e8f105eb5647bde7ef4543f406ea771d17.png | complex | <table><tr><td></td><td colspan="2">PCI</td><td></td><td colspan="2">No PCI</td><td></td><td></td></tr><tr><td>Study</td><td>Events</td><td>Total</td><td>Incidence (%)</td><td>Events</td><td>Total</td><td>Incidence (%)</td><td>Weight (%)</td></tr><tr><td>VALG</td><td>7</td><td>136</td><td>5.1</td><td>16</td><td>145</td... | <table><tr><td></td><td colspan="2">PCI</td><td></td><td colspan="2">No PCI</td><td></td><td></td></tr></table> | <table><tr><td>Study</td><td>Events</td><td>Total</td><td>Incidence (%)</td><td>Events</td><td>Total</td><td>Incidence (%)</td><td>Weight (%)</td></tr><tr><td>VALG</td><td>7</td><td>136</td><td>5.1</td><td>16</td><td>145</td><td>11.0</td><td>10.5</td></tr><tr><td>MDACC</td><td>2</td><td>46</td><td>4.3</td><td>14</td><t... |
a18ad8121e727e9f5677515625e75af183bbe0d8a90300733ad75b1191956e5b.png | simple | <table><tr><td></td><td>Placebo(n = 62)</td><td>30 mg/d LDX(n = 119)</td><td>50 mg/d LDX(n = 116)</td><td>70 mg/d LDX(n = 121)</td><td>All LDX Doses(n = 356)</td></tr><tr><td>Baseline[Mean (SD)]</td><td>6.9(1.34)</td><td>7.4(1.69)</td><td>7.4(1.51)</td><td>7.2(1.42)</td><td>7.3(1.54)</td></tr><tr><td>Endpoint[Mean (SD)... | <table><tr><td></td><td>Placebo(n = 62)</td><td>30 mg/d LDX(n = 119)</td><td>50 mg/d LDX(n = 116)</td><td>70 mg/d LDX(n = 121)</td><td>All LDX Doses(n = 356)</td></tr><tr><td>Baseline[Mean (SD)]</td><td>6.9(1.34)</td><td>7.4(1.69)</td><td>7.4(1.51)</td><td>7.2(1.42)</td><td>7.3(1.54)</td></tr></table> | <table><tr><td>Endpoint[Mean (SD)]</td><td>7.0(1.33)</td><td>7.2(1.21)</td><td>7.0(1.44)</td><td>7.0(1.61)</td><td>7.1(1.43)</td></tr><tr><td>Change[LS Mean (SE)]</td><td>-0.1(0.15)</td><td>-0.1(0.11)</td><td>-0.3(0.11)</td><td>-0.2(0.11)</td><td>-0.2(0.07)</td></tr></table> |
800d4679934d00e757078d742e1815075cc00e875d34c3992f3400d70e21cf86.png | simple | <table><tr><td>Week</td><td>Weekly theme</td></tr><tr><td>1</td><td>Introduction and briefing on the aims of the rehabilitation program• Introduction to group• Introduction of the concept of self-efficacy• Information on post-stroke balance self-efficacy and rehabilitation</td></tr><tr><td>2</td><td>U... | <table><tr><td>Week</td><td>Weekly theme</td></tr><tr><td>1</td><td>Introduction and briefing on the aims of the rehabilitation program• Introduction to group• Introduction of the concept of self-efficacy• Information on post-stroke balance self-efficacy and rehabilitation</td></tr><tr><td>2</td><td>Understanding the r... | <table><tr><td></td><td>vioral changes related to ADL• Setting personal goals for ADL• Planning to achieve personal goals in small stages• Recognizing potential hazards and planning for safety</td></tr><tr><td>6</td><td>Implementing and reviewing behavioral changes related to social activities• Setting personal goals f... |
d748a8bc7e4b428d98921bdca9f8b3a11c0700ecd6cabc45b76ad66daa54ea2e.png | complex | <table><tr><td></td><td>Athletes</td><td>Controls</td><td><i>P</i>‐values</td></tr><tr><td colspan="4">Baseline characteristics</td></tr><tr><td><i>n</i></td><td>19</td><td>8</td><td></td></tr><tr><td>Age (year)</td><td>26 ± 5</td><td>31 ± 4</td><td>0.07</td></tr><tr><td>Height (m)</td><td>1.77 ± 0... | <table><tr><td></td><td>Athletes</td><td>Controls</td></tr><tr><td colspan="3">Baseline characteristics</td></tr><tr><td>n</td><td>19</td><td>8</td></tr><tr><td>Age (year)</td><td>26 ± 5</td><td>31 ± 4</td></tr><tr><td>Height (m)</td><td>1.77 ± 0.08</td><td>1.80 ± 0.10</td></tr><tr><td>Body mass (kg)</td><td>72.6 ± 9.5... | <table><tr><td>P‐values</td></tr><tr><td>Baseline characteristics</td></tr><tr><td></td></tr><tr><td>0.07</td></tr><tr><td>0.47</td></tr><tr><td>0.02</td></tr><tr><td>0.01</td></tr><tr><td><0.001</td></tr><tr><td>Resting values</td></tr><tr><td></td></tr><tr><td>0.20</td></tr><tr><td>0.92</td></tr><tr><td>0.75</td></tr... |
1053c1b6363fcc2af139c7314f7036e005e479bcf7d483dba164ffb48da01de6.png | complex | <table><tr><td></td><td>Healthy (<i>n</i> = 18)</td><td>Post-OP (<i>n</i> = 28)</td><td>Sepsis (<i>n</i> = 15)</td></tr><tr><td>IL-6 (pg/ml)</td><td>0.0; 0.0–0.8</td><td>216.7; 48.8–360.5</td><td>577.7; 521.9–583.2</td></tr><tr><td rowspan="3"><i>P</i>-value</td><td colspan="3">Healthy versus Post-OP:... | <table><tr><td></td><td>Healthy (n = 18)</td><td>Post-OP (n = 28)</td><td>Sepsis (n = 15)</td></tr><tr><td>IL-6 (pg/ml)</td><td>0.0; 0.0–0.8</td><td>216.7; 48.8–360.5</td><td>577.7; 521.9–583.2</td></tr><tr><td rowspan="2">P-value</td><td colspan="3">Healthy versus Post-OP: P < .001***</td></tr><tr><td colspan="3">Heal... | <table><tr><td></td><td>Healthy (n = 18)</td><td>Post-OP (n = 28)</td><td>Sepsis (n = 15)</td></tr><tr><td>P-value</td><td colspan="3">Post-OP versus Sepsis: P <.001***</td></tr><tr><td>TRX1 (ng/ml)</td><td>11.0; 10.0–12.1</td><td>11.3; 9.6–15.6</td><td>34.0; 19.7–57.7</td></tr><tr><td rowspan="3">P-value</td><td colsp... |
6c7d06d1be2db3e85fa021b4f605c47dcdb7e6ef5868ec260b5cf4b6cd184b6b.png | simple | <table><tr><td>No.</td><td>Age</td><td>Sex</td><td>AQP1/4 tissue</td><td>Brief history</td><td>Probable cause/</td></tr><tr><td> </td><td>(years)</td><td> </td><td>immunoreactivity*</td><td> </td><td>underlying cause of</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td>CPM</td></tr><tr><td>1</td><td>56... | <table><tr><td>No.</td><td>Age</td><td>Sex</td><td>AQP1/4 tissue</td><td>Brief history</td></tr><tr><td></td><td>(years)</td><td></td><td>immunoreactivity*</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1</td><td>56</td><td>M</td><td>0</td><td>Alcoholism; nausea and vomiting 1 week; hyp... | <table><tr><td>Probable cause/</td></tr><tr><td>underlying cause of</td></tr><tr><td>CPM</td></tr><tr><td>Rapid correction of hyponatremia</td></tr><tr><td>Dehydration, malnutrition and hypernatremia</td></tr><tr><td>Orthotopic liver transplant</td></tr><tr><td>SIAD secondary to small-cell lung carcinoma</td></tr><tr><... |
d1da8022d05e7f0364cd0c78737f441dcf7db58532b1f088aeca114a80d69e18.png | complex | <table><tr><td>Health risk behavior</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>N</td><td>(%)</td><td>N</td><td>(%)</td></tr><tr><td>Current smoking</td><td>10784</td><td>(57.3)</td><td>3099</td><td>(15.6)</td></tr><tr><td>Excess alcohol consumption</td><td>5177</td><td>(27.4)</td><td>11... | <table><tr><td>Health risk behavior</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>N</td><td>(%)</td><td>N</td><td>(%)</td></tr><tr><td>Current smoking</td><td>10784</td><td>(57.3)</td><td>3099</td><td>(15.6)</td></tr><tr><td></td><td>5177</td><td></td><td>115</td><td>(5</td></tr></table> | <table><tr><td>Health risk behavior</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>N</td><td>(%)</td><td>N</td><td>(%)</td></tr><tr><td>Excess alcohol consumption</td><td></td><td>(27.4)</td><td>5</td><td>.8)</td></tr><tr><td>Physical inactivity</td><td>13989</td><td>(71.2)</td><td>14926</t... |
2bdbc72014707ac874252cab2f6e187c01b730cc79bf6b6084e256aa4ce18fa4.png | simple | <table><tr><td></td><td>Time-dependent Burden</td><td>Emotional Burden</td><td>Exisitential Burden</td><td>Physical Burden</td><td>Service-related Burden</td><td>Total Care Burden</td><td>BIC Total</td></tr><tr><td>SF-8</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> PF (Physical Functi... | <table><tr><td></td><td>Time-dependent Burden</td><td>Emotional Burden</td><td>Exisitential Burden</td><td>Physical Burden</td><td>Service-related Burden</td><td>Total Care Burden</td><td>BIC Total</td></tr><tr><td>SF-8</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>PF (Physical Functio... | <table><tr><td>al Health)</td><td></td><td></td><td>5</td><td>.55</td><td>29</td><td></td><td>64</td></tr><tr><td>p-value</td><td>0.0001</td><td>0.0001</td><td>0.0001</td><td>0.0001</td><td>0.0001</td><td>0.0001</td><td>0.0001</td></tr><tr><td>CES-D</td><td>0.49</td><td>0.54</td><td>0.53</td><td>0.48</td><td>0.32</td><... |
b2c91eedf3760b95ba9bd3f65e47501cfec3cf5250f7ac7a8434092c8200a1ca.png | simple | <table><tr><td></td><td>Controls (<i>n</i> = 1846)</td><td>Cases (<i>n</i> = 695)</td><td><i>p</i>-Value <sup>2</sup></td></tr><tr><td>Age (years), mean (SD)</td><td>56.1 (9.1)</td><td>56.4 (9.6)</td><td>0.44</td></tr><tr><td>Female, <i>n</i> (%)</td><td>596 (32.3)</td><td>222(31.9)</td><td>0.87</td></tr><tr><td>Family... | <table><tr><td></td><td>Controls (n = 1846)</td><td>Cases (n = 695)</td><td>p-Value 2</td></tr><tr><td>Age (years), mean (SD)</td><td>56.1 (9.1)</td><td>56.4 (9.6)</td><td>0.44</td></tr><tr><td>Female, n (%)</td><td>596 (32.3)</td><td>222(31.9)</td><td>0.87</td></tr><tr><td>Family history of colorectal cancer (yes) 1, ... | <table><tr><td></td><td>Controls (n = 1846)</td><td>Cases (n = 695)</td><td>p-Value 2</td></tr><tr><td><12 years</td><td>282 (15.6)</td><td>252 (36.3)</td><td><0.001</td></tr><tr><td>≥12 years</td><td>1521 (84.4)</td><td>443 (63.7)</td><td></td></tr><tr><td>Smoking status, n (%)</td><td></td><td></td><td></td></tr><tr>... |
536c84c6458a1031d370bc3530c53c37d2d415de2167310ef184886c5a1df049.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">Microaerobic culture</td><td></td></tr><tr><td></td><td></td><td></td><td>+</td><td>-</td><td>Total</td></tr><tr><td>4.1 <i>Campylobacter coli </i>detection in faecal samples</td><td></td><td>+</td><td>125</td><td>1</td><td>126</td></tr><tr><td></td><td>Real-time PC... | <table><tr><td></td><td></td><td></td><td colspan="2">Microaerobic culture</td><td></td></tr><tr><td></td><td></td><td></td><td>+</td><td>-</td><td>Total</td></tr><tr><td>4.1 Campylobacter coli detection in faecal samples</td><td></td><td>+</td><td>125</td><td>1</td><td>126</td></tr><tr><td></td><td>Real-time PCR</td><... | <table><tr><td></td><td></td><td></td><td colspan="2">Microaerobic culture</td><td></td></tr><tr><td></td><td></td><td></td><td>+</td><td>-</td><td>Total</td></tr><tr><td></td><td>Real-time PCR</td><td>-</td><td>3</td><td>47</td><td>50</td></tr><tr><td></td><td></td><td>Total</td><td>37</td><td>49</td><td>86</td></tr><... |
7e4ce9946ee017f1c2cf35e5a61b5e253dc038d2dcde994d2f920062e26c5e9f.png | complex | <table><tr><td rowspan="2">Sequences</td><td colspan="2">Descent</td><td colspan="2">Ascent</td><td colspan="2">Stop (Life Bases)</td><td><i>P</i></td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td></td></tr><tr><td>Feeling pain (FP)</td><td>10</td><td>31.2</td><td>14</td><td>43.8</td><td>8</t... | <table><tr><td rowspan="2">Sequences</td><td colspan="2">Descent</td><td colspan="2">Ascent</td><td colspan="2">Stop (Life Bases)</td><td>P</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td></td></tr><tr><td>Feeling pain (FP)</td><td>10</td><td>31.2</td><td>14</td><td>43.8</td><td>8</td><td>2... | <table><tr><td rowspan="2">Sequences</td><td colspan="2">Descent</td><td colspan="2">Ascent</td><td colspan="2">Stop (Life Bases)</td><td>P</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td></td></tr><tr><td>Total</td><td>24</td><td>18.2</td><td>47</td><td>35.6</td><td>61</td><td>46.2</td><td... |
7083736ee80d0eb52577eb8668050fa2068964b062ed9b63437a773f8db36c98.png | complex | <table><tr><td>Characteristics</td><td>Parameter estimate</td><td>Standard error</td><td>Odds ratio (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td colspan="5">Univariate analysis</td></tr><tr><td> Age</td><td>0.006</td><td>0.010</td><td>1.01 (0.99,1.03)</td><td>0.563</td></tr><tr><td> BMI</td><td>0.027</td><td>0.026... | <table><tr><td>Characteristics</td><td>Parameter estimate</td><td>Standard error</td><td>Odds ratio (95 % CI)</td><td>P-value</td></tr><tr><td colspan="5">Univariate analysis</td></tr><tr><td>Age</td><td>0.006</td><td>0.010</td><td>1.01 (0.99,1.03)</td><td>0.563</td></tr><tr><td>BMI</td><td>0.027</td><td>0.026</td><td>... | <table><tr><td>Characteristics</td><td>Parameter estimate</td><td>Standard error</td><td>Odds ratio (95 % CI)</td><td>P-value</td></tr><tr><td>Depression</td><td>1.294</td><td>0.797</td><td>3.65 (0.76,17.4)</td><td>0.105</td></tr><tr><td>Anxiety</td><td>−0.124</td><td>0.823</td><td>0.88 (0.18,4.43)</td><td>0.880</td></... |
600450c2d0bb0a524e589664b8fbc352f7aeab62a989f7c50f59a50791eb1776.png | complex | <table><tr><td colspan="2">Variable</td><td>Number<sup>b</sup></td><td>Percent</td></tr><tr><td rowspan="4">Pregnancy</td><td>1st trimester</td><td>710</td><td>18.40</td></tr><tr><td>2nd trimester</td><td>1344</td><td>34.83</td></tr><tr><td>3rd trimester</td><td>1557</td><td>40.35</td></tr><tr><td>Postpartum 1 m</td><t... | <table><tr><td colspan="2">Variable</td><td>Numberb</td><td>Percent</td></tr><tr><td>Pregnancy</td><td>1st trimester</td><td>710</td><td>18.40</td></tr></table> | <table><tr><td colspan="2">Variable</td><td>Numberb</td><td>Percent</td></tr><tr><td rowspan="3">Pregnancy</td><td>2nd trimester</td><td>1344</td><td>34.83</td></tr><tr><td>3rd trimester</td><td>1557</td><td>40.35</td></tr><tr><td>Postpartum 1 m</td><td>248</td><td>6.43</td></tr><tr><td rowspan="3">Age (years)</td><td>... |
19168b55ee1c4b4cc04413d6c295d226efe2a9a9daa2e8018188f95bdac27dd7.png | complex | <table><tr><td>Parameters</td><td>Early RRT(<i>n</i> = 58)</td><td>Standard RRT(<i>n</i> = 60)</td><td><i>P</i> value</td></tr><tr><td>Age (years), mean (SD)</td><td>67.5 (15.0)</td><td>66.7 (16.7)</td><td>0.80</td></tr><tr><td>Male, <i>n</i> (%)</td><td>29 (50)</td><td>29 (48.3)</td><td>0.86</td></tr><tr><td>ICU, <i>n... | <table><tr><td>Parameters</td><td>Early RRT(n = 58)</td><td>Standard RRT(n = 60)</td><td>P value</td></tr><tr><td>Age (years), mean (SD)</td><td>67.5 (15.0)</td><td>66.7 (16.7)</td><td>0.80</td></tr><tr><td>Male, n (%)</td><td>29 (50)</td><td>29 (48.3)</td><td>0.86</td></tr><tr><td>ICU, n (%)</td><td></td><td></td><td>... | <table><tr><td>Parameters</td><td>Early RRT(n = 58)</td><td>Standard RRT(n = 60)</td><td>P value</td></tr><tr><td>Vasopressors, n (%)</td><td>45 (77.6)</td><td>47 (78.3)</td><td>0.92</td></tr><tr><td>Sepsis, n (%)</td><td>37 (63.8)</td><td>32 (53.3)</td><td>0.25</td></tr><tr><td>APACHE II score, mean (SD)</td><td>24.5 ... |
0dd7c3a02f46a4fe1d0d5ba3f7e22919ac183c7994cdadb86b0d45a8b1f05997.png | simple | <table><tr><td>Kinesthetic variables</td><td>Test session 1 Mean (SD)</td><td>Test session 2 Mean (SD)</td><td>Mean difference (SDdiff), 95% CI</td><td>ICC<sub>2,1</sub>(95% CI)</td><td>95% LOA<sub>ratio</sub></td></tr><tr><td>TE20</td><td>0.98 (0.37)</td><td>1.03 (0.51)</td><td>0.05 (0.35), -0.10 – 0.19</td><td>... | <table><tr><td>Kinesthetic variables</td><td>Test session 1 Mean (SD)</td><td>Test session 2 Mean (SD)</td></tr><tr><td>TE20</td><td>0.98 (0.37)</td><td>1.03 (0.51)</td></tr><tr><td>TE40</td><td>1.20 (0.52)</td><td>1.26 (0.75)</td></tr><tr><td>TF20</td><td>1.55 (0.66)</td><td>1.29 (0.70)</td></tr><tr><td>TF40</td><td>0... | <table><tr><td>Mean difference (SDdiff), 95% CI</td><td>ICC2,1(95% CI)</td><td>95% LOAratio</td></tr><tr><td>0.05 (0.35), -0.10 – 0.19</td><td>0.70 (0.42 – 0.86)</td><td>0.57 – 1.78</td></tr><tr><td>-0.06 (0.84), -0.41 – 0.30</td><td>0.16 (-0.27 – 0.53)</td><td>0.31 – 3.09</td></tr><tr><td>-0.26 (0.55), -0.49 – -0.03</... |
a44d8315e97a1ddf2aa2a946e99ccef8d7e8927fb0089fb4f8af30328efbf31a.png | simple | <table><tr><td>Parameter</td><td>Exposed</td><td>Controls</td></tr><tr><td>CC16 [pg/mL]</td><td>6.7 (3.7 - 9.0)</td><td>7.2 (5.0 - 8.7)</td></tr><tr><td>IL-6 [pg/mL]</td><td><4.7 (<4.7 - 7.4)</td><td><4.7 (<4.7 - 23.9)</td></tr><tr><td>IL-8 [pg/mL]</td><td>21.7 (11.0 - 38.9)</td><td>16.5 (11.4 - 34.4)</td><... | <table><tr><td>Parameter</td><td>Exposed</td><td>Controls</td></tr><tr><td>CC16 [pg/mL]</td><td>6.7 (3.7 - 9.0)</td><td>7.2 (5.0 - 8.7)</td></tr><tr><td>IL-6 [pg/mL]</td><td><4.7 (<4.7 - 7.4)</td><td><4.7 (<4.7 - 23.9)</td></tr><tr><td>IL-8 [pg/mL]</td><td>21.7 (11.0 - 38.9)</td><td>16.5 (11.4 - 34.4)</td></tr></table> | <table><tr><td>BPI [pg/mL]</td><td>3201 (<408 - 4741)</td><td>2310 (<408- 4102)</td></tr><tr><td>LBP [μg/mL]</td><td>19.9 (15.8 - 25.2)</td><td>22.0 (15.8 - 29.2)</td></tr><tr><td>sCD14 [μg/mL]</td><td>1.3 (1.0 - 1.8)</td><td>1.2 (1.1 - 2.1)</td></tr></table> |
9b87723c6a7b70525c775473a13be6bb1060f61a39cde6269cf4bca71f784891.png | complex | <table><tr><td rowspan="2">Precursor</td><td colspan="2">Bond length in precursor (Å)</td><td colspan="4">Bond length in transition state structures (Å)</td></tr><tr><td>M-S bond <sup>a</sup></td><td>C-S bond</td><td>M-S bond <sup>a</sup></td><td>C-S bond</td><td>C-N bond</td><td>N-H bond <sup>b</sup></td><... | <table><tr><td rowspan="2">Precursor</td><td colspan="2">Bond length in precursor (Å)</td><td colspan="4">Bond length in transition state structures (Å)</td></tr><tr><td>M-S bond a</td><td>C-S bond</td><td>M-S bond a</td><td>C-S bond</td><td>C-N bond</td><td>N-H bond b</td></tr><tr><td>Ag(SCO</td><td>2.</td><td></td>... | <table><tr><td>Ph)</td><td>540</td><td>1.820</td><td>8</td><td>.660</td><td>3</td><td></td></tr><tr><td>Cu(SCOPh)</td><td>2.348</td><td>1.812</td><td>2.173</td><td>2.669</td><td>1.601</td><td>1.060</td></tr><tr><td>Cd(SCOPh)2</td><td>2.632</td><td>1.803</td><td>2.454</td><td>2.801</td><td>1.564</td><td>1.102</td></tr><... |
fc49a3f39df864c3a9b9ae4a798b2eeef5080224906020ae9b5eec66adbc8227.png | complex | <table><tr><td></td><td><i>Number</i></td><td><i>Incidence (%)</i></td><td><i>Anomalies (%)</i></td></tr><tr><td colspan="4">Benign anomalies</td></tr><tr><td>CA from RCS</td><td>8</td><td>1.07</td><td>24.24</td></tr><tr><td>Absence of LMA</td><td>7</td><td>0.93</td><td>21.21</td></tr><tr><td>Posterior RCA</td><td>1</t... | <table><tr><td></td><td>Number</td><td>Incidence (%)</td><td>Anomalies (%)</td></tr><tr><td colspan="4">Benign anomalies</td></tr><tr><td>CA from RCS</td><td>8</td><td>1.07</td><td>24.24</td></tr></table> | <table><tr><td>Absence of LMA</td><td>7</td><td>0.93</td><td>21.21</td></tr><tr><td>Posterior RCA</td><td>1</td><td>0.13</td><td>3.03</td></tr><tr><td colspan="4">Potentially clinically significant anomalies</td></tr><tr><td>Superior RCA</td><td>7</td><td>0.93</td><td>21.21</td></tr><tr><td>CFX from RCS</td><td>4</td><... |
e40d0d7b60a4f54807a8baa400cb94c5c6c187ba37a98562fa462b015a306db5.png | simple | <table><tr><td>Metric</td><td>Value</td></tr><tr><td>Families making <Q 2000<sup>a</sup> per month</td><td>66 %</td></tr><tr><td>Families making Q 2000–4000<sup>a</sup> per month</td><td>34 %</td></tr><tr><td>Average persons per household</td><td>6.4</td></tr><tr><td>Average children per household</td><td>3.3<... | <table><tr><td>Metric</td><td>Value</td></tr><tr><td>Families making <Q 2000a per month</td><td>66 %</td></tr></table> | <table><tr><td>Families making Q 2000–4000a per month</td><td>34 %</td></tr><tr><td>Average persons per household</td><td>6.4</td></tr><tr><td>Average children per household</td><td>3.3</td></tr></table> |
7d56d0bf98877c7180c6301713e9c125f513282a5e878188efa6f49866c9203c.png | simple | <table><tr><td></td><td># Samples</td><td># Pairs</td><td># IBD Segments</td><td>Mean/Median/SD # IBD Segments/Pair</td><td>Mean/Median/SD Size (Mb)/Segment</td><td>Mean/Median/SD Size (Mb)/Pair</td></tr><tr><td>NLD</td><td>92</td><td>4186</td><td>4548</td><td>1.09/1/1.05</td><td>3.99/3.57/1.36</td><td>4.34/3.5/4.57</t... | <table><tr><td></td><td># Samples</td><td># Pairs</td><td># IBD Segments</td><td>Mean/Median/SD # IBD Segments/Pair</td><td>Mean/Median/SD Size (Mb)/Segment</td><td>Mean/Median/SD Size (Mb)/Pair</td></tr><tr><td>NLD</td><td>92</td><td>4186</td><td>4548</td><td>1.09/1/1.05</td><td>3.99/3.57/1.36</td><td>4.34/3.5/4.57</t... | <table><tr><td>p-value</td><td></td><td></td><td></td><td><0.0001</td><td><0.0001</td><td><0.0001</td></tr></table> |
9fd3588efc04293acef8d74b01eeb04d545230a5c0d3a6ad43af095ba1ee7cf2.png | simple | <table><tr><td></td><td>Baseline</td><td>Normal protein</td><td>High protein</td><td>Reference range</td></tr><tr><td>Glucose mg/dL</td><td>83 ± 12</td><td>85 ± 14</td><td>84 ± 19</td><td>65–99</td></tr><tr><td>BUN mg/dL</td><td>22 ± 5</td><td>23 ± 5</td><td>23 ± 6</td><td>7–25... | <table><tr><td></td><td>Baseline</td><td>Normal protein</td><td>High protein</td><td>Reference range</td></tr><tr><td>Glucose mg/dL</td><td>83 ± 12</td><td>85 ± 14</td><td>84 ± 19</td><td>65–99</td></tr><tr><td>BUN mg/dL</td><td>22 ± 5</td><td>23 ± 5</td><td>23 ± 6</td><td>7–25</td></tr><tr><td>Creatinine mg/dL</td><td... | <table><tr><td>L</td><td>± 0.3</td><td>.3</td><td>± 0.3</td><td>3.7</td></tr><tr><td>Albumin/Globulin ratio</td><td>1.9 ± 0.2</td><td>1.8 ± 0.2</td><td>1.8 ± 0.2</td><td>1.0–2.5</td></tr><tr><td>Total Bilirubin mg/dL</td><td>0.7 ± 0.3</td><td>0.7 ± 0.2</td><td>0.7 ± 0.3</td><td>0.2–1.2</td></tr><tr><td>Alkaline Phospha... |
15d4433ab62eacdd28d4abcaf7847d207579980354953492516720c682d9bc99.png | simple | <table><tr><td></td><td>Study 1</td><td>Study 2</td></tr><tr><td>Age, y</td><td>24 ± 4</td><td>26 ± 3</td></tr><tr><td>Body mass, kg</td><td>72.9 ± 3.9</td><td>65.8 ± 9.0</td></tr><tr><td>Height, m</td><td>1.70 ± 0.09</td><td>1.70 ± 0.10</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>25.0 ... | <table><tr><td></td><td>Study 1</td><td>Study 2</td></tr><tr><td>Age, y</td><td>24 ± 4</td><td>26 ± 3</td></tr><tr><td>Body mass, kg</td><td>72.9 ± 3.9</td><td>65.8 ± 9.0</td></tr><tr><td>Height, m</td><td>1.70 ± 0.09</td><td>1.70 ± 0.10</td></tr><tr><td>BMI, kg/m2</td><td>25.0 ± 1.1</td><td>22.8 ± 0.9</td></tr><tr><td... | <table><tr><td></td><td>Study 1</td><td>Study 2</td></tr><tr><td>C-reactive protein, nmol/L</td><td>18.4 ± 19.9</td><td>11.0 ± 5.2</td></tr><tr><td>Glucose, mmol/L</td><td>4.7 ± 0.2</td><td>4.8 ± 0.5</td></tr><tr><td>Insulin, pmol/L</td><td>41 ± 28</td><td>41 ± 27</td></tr><tr><td>Systolic blood pressure, mmHg</td><td>... |
ec847a1bf6d6cf9081e8446a0aec92255008cad8d54da90ed517438ca295667e.png | complex | <table><tr><td>Compound</td><td>LOD (μg/L)</td><td>LOQ (μg/L)</td><td>RSD (%)</td><td>Recovery (%)</td><td>Method</td><td>References</td></tr><tr><td>Caffeine</td><td>3610</td><td>10,940</td><td>1.7</td><td>95 ± 7</td><td rowspan="3">HPLC–DAD–MS</td><td rowspan="3">[4]</td></tr><tr><td>Theobr... | <table><tr><td>Compound</td><td>LOD (μg/L)</td><td>LOQ (μg/L)</td><td>RSD (%)</td><td>Recovery (%)</td><td>Method</td><td>References</td></tr><tr><td>Caffeine</td><td>3610</td><td>10,940</td><td>1.7</td><td>95 ± 7</td><td rowspan="3">HPLC–DAD–MS</td><td rowspan="3">[4]</td></tr><tr><td>Theobromine</td><td>30</td><td>10... | <table><tr><td>Caffeine</td><td>2</td><td>40</td><td>3</td><td>99 ± 2</td><td rowspan="3">Fluorescence</td><td rowspan="3">This study</td></tr><tr><td>Theobromine</td><td>6</td><td>20</td><td>3</td><td>–</td></tr><tr><td>Trigonelline</td><td>7</td><td>20</td><td>4</td><td>99 ± 2</td></tr></table> |
6e602fdfcf15def87c85aced6f3f3b0742e38b36a5e793f5c731e9b6d226043e.png | simple | <table><tr><td>Inclusion Criteria</td><td>Exclusion Criteria</td></tr><tr><td>◆ Student at Haskell Indian Nations University◆ Age at least 18 years or older◆ Have a valid college/university email address, telephone number, and home address◆ Willing to participate in all study components◆ W... | <table><tr><td>Inclusion Criteria</td><td>Exclusion Criteria</td></tr></table> | <table><tr><td>◆ Student at Haskell Indian Nations University◆ Age at least 18 years or older◆ Have a valid college/university email address, telephone number, and home address◆ Willing to participate in all study components◆ Willing to be followed-up over several years (1-4 years, depending on freshman cohort year)</t... |
92491a8ce4648c9b351d39c27138cf8aa8c0432f41af8258b745dfc9b8053bdc.png | complex | <table><tr><td>Mean radio-density</td><td colspan="3">Technique</td><td colspan="3">p-values*</td></tr><tr><td>At depth of</td><td>1 (Syringe Spreader)</td><td>2 (Syringe Lentulo Spiral)</td><td>3 (Specially Designed Paste Carrier)</td><td>1 cf 2</td><td>1 cf 3</td><td>2 cf 3</td></tr><tr><td>1 mm</td><td>6.9 (3.2-10.5... | <table><tr><td>Mean radio-density</td><td colspan="3">Technique</td><td colspan="3">p-values*</td></tr><tr><td>At depth of</td><td>1 (Syringe Spreader)</td><td>2 (Syringe Lentulo Spiral)</td><td>3 (Specially Designed Paste Carrier)</td><td>1 cf 2</td><td>1 cf 3</td><td>2 cf 3</td></tr><tr><td>1 mm</td><td>6.9 (3.2-10.5... | <table><tr><td>Mean radio-density</td><td colspan="3">Technique</td><td colspan="3">p-values*</td></tr><tr><td>Overall density</td><td>14.2 (9.9-18.6)</td><td>20.8 (16.0-25.6)</td><td>33.83 (30.2-37.5)</td><td>0.077</td><td>0.001</td><td>0.001</td></tr></table> |
9a110546e390374524a09302363e58e988f834ad9f1d443b25ad1005112ef13d.png | complex | <table><tr><td>Vasectomy technique</td><td>Early recanalization</td><td colspan="3">Vasectomy outcome</td><td>Total</td></tr><tr><td></td><td></td><td>Failure<sup>a </sup>n (%)</td><td>Success<sup>b </sup>n (%)</td><td>Indeterminate<sup>c </sup>n (%)</td><td></td></tr><tr><td>FI trial</td><td></td><td></td><td></td><td... | <table><tr><td>Vasectomy technique</td><td>Early recanalization</td><td colspan="3">Vasectomy outcome</td><td>Total</td></tr><tr><td></td><td></td><td>Failurea n (%)</td><td>Successb n (%)</td><td>Indeterminatec n (%)</td><td></td></tr></table> | <table><tr><td>FI trial</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>LE</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Yes</td><td>46 (87)</td><td>49 (15)</td><td>10 (31)</td><td>105 (25)</td></tr><tr><td></td><td>No</td><td>7 (13)</td><td>282 (85)</td><td>22 (69)</td><td>311 (7... |
09e9dd23fbfa69e927f664ea343e6904218a7fb4eedf82565ad1b56474360141.png | complex | <table><tr><td rowspan="2">Time interval(months)</td><td colspan="2">Primary endpoint*</td><td rowspan="2">ARR(%)</td><td rowspan="2">RRR[95% CIs] (%)</td><td rowspan="2">NNT(per month)</td></tr><tr><td>Clopidogrel(%)</td><td>Placebo(%)</td></tr><tr><td colspan="6">CURE trial</td></tr><tr><td>0–1</td><td>4.3</td>... | <table><tr><td rowspan="2">Time interval(months)</td><td colspan="2">Primary endpoint*</td><td rowspan="2">ARR(%)</td><td rowspan="2">RRR[95% CIs] (%)</td><td rowspan="2">NNT(per month)</td></tr><tr><td>Clopidogrel(%)</td><td>Placebo(%)</td></tr><tr><td colspan="6">CURE trial</td></tr><tr><td>0–1</td><td>4.3</td><td>5.... | <table><tr><td rowspan="2">Time interval(months)</td><td colspan="2">Primary endpoint*</td><td rowspan="2">ARR(%)</td><td rowspan="2">RRR[95% CIs] (%)</td><td rowspan="2">NNT(per month)</td></tr><tr><td>Clopidogrel(%)</td><td>Placebo(%)</td></tr><tr><td>6–9</td><td>1.3</td><td>1.4</td><td>0.1</td><td>6 [–34, 34]</td><t... |
6c9a7f53ad164f057147e20adb01d37215c0fe641497796578237d1d77c5e425.png | complex | <table><tr><td>Nutrient</td><td colspan="2">Unfortified cereal (<i>n</i> = 37)</td><td colspan="2">Fortified cereal (<i>n</i> = 34)</td><td><i>P</i> value<sup>b</sup></td></tr><tr><td></td><td>Pre-intervention</td><td>Post-intervention</td><td>Pre-intervention</td><td>Post-intervention</td><td></td></tr><tr><td></td><t... | <table><tr><td>Nutrient</td><td colspan="2">Unfortified cereal (n = 37)</td></tr><tr><td></td><td>Pre-intervention</td><td>Post-intervention</td></tr><tr><td></td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Vitamin B1 (mg)</td><td>1.1 (0.40)</td><td>1.3 (0.35)**</td></tr><tr><td>Vitamin B2 (mg)</td><td>1.0 (0.41)<... | <table><tr><td colspan="2">Fortified cereal (n = 34)</td><td>P valueb</td></tr><tr><td>Pre-intervention</td><td>Post-intervention</td><td></td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td></td></tr><tr><td>1.2 (0.50)</td><td>2.2 (0.36)**</td><td><0.001</td></tr><tr><td>1.2 (0.43)</td><td>2.7 (0.50)**</td><td><0.001... |
3dcaa4f13452329176c921c7e03d518386916eec991bc9aa5d29e7c68c42585a.png | complex | <table><tr><td></td><td colspan="3">Group</td></tr><tr><td>Variable</td><td>Dry</td><td>10 kg milk</td><td>20 kg milk</td></tr><tr><td>Diameter of vein (cm)</td><td>0.69 ± 0.13 (0.28 - 1.10)</td><td>0.63 ± 0.09 (0.38 - 0.87)</td><td>0.87 ± 0.15 (0.54 - 1.32)</td></tr><tr><td>Maximum blood flow velocity (... | <table><tr><td></td><td colspan="2">Group</td></tr><tr><td>Variable</td><td>Dry</td><td>10 kg milk</td></tr><tr><td>Diameter of vein (cm)</td><td>0.69 ± 0.13 (0.28 - 1.10)</td><td>0.63 ± 0.09 (0.38 - 0.87)</td></tr><tr><td>Maximum blood flow velocity (cm/s)</td><td>61.78 ± 12.8 (30.0 - 94.9)</td><td>118.08 ± 19.9 (77.6... | <table><tr><td>Group</td></tr><tr><td>20 kg milk</td></tr><tr><td>0.87 ± 0.15 (0.54 - 1.32)</td></tr><tr><td>119.13 ± 16.0 (78.8 - 159.8)</td></tr><tr><td>7.87 ± 1.40 (3.4 - 11.0)</td></tr><tr><td>85.15 ± 12.3*(59.6 - 116.5)</td></tr><tr><td>1.57 ± 0.40 (0.8 - 3.1)</td></tr></table> |
e7357b2edb7f94ae15bc7551bbaaab96d752beaf73bc87f9cb4b91a1f7572e01.png | simple | <table><tr><td></td><td>Food-specific decentering</td><td>Awareness of food thoughts</td><td>Meditation experience</td></tr><tr><td>Food cravings</td><td>−0.62<sup>a</sup></td><td>0.27</td><td>−0.47 <sup>a</sup></td></tr><tr><td>Food-specific decentering</td><td></td><td>−0.29</td><td>0.25</td></tr><t... | <table><tr><td></td><td>Food-specific decentering</td><td>Awareness of food thoughts</td><td>Meditation experience</td></tr><tr><td>Food cravings</td><td>−0.62a</td><td>0.27</td><td>−0.47 a</td></tr></table> | <table><tr><td>Food-specific decentering</td><td>−0.29</td><td>0.25</td></tr><tr><td>Awareness of food thoughts</td><td></td><td>−0.20</td></tr></table> |
d520c5b43806eb59366b303dbdf57619b80336b5cad2f870107f96bf31433802.png | simple | <table><tr><td>Value</td><td>Uniform<sup>a</sup></td><td>Uniform</td><td>Uniform</td></tr><tr><td></td><td></td><td>Placental<sup>b</sup></td><td>Peripheral<sup>c</sup></td></tr><tr><td>Sensitivity Histology (Median, CI)</td><td>0.497 (0.414, 0.588)</td><td>0.498 (0.410, 0.589)</td><td>0.504 (0.397, 0.646)</td></tr><tr... | <table><tr><td>Value</td><td>Uniforma</td><td>Uniform</td></tr><tr><td></td><td></td><td>Placentalb</td></tr><tr><td>Sensitivity Histology (Median, CI)</td><td>0.497 (0.414, 0.588)</td><td>0.498 (0.410, 0.589)</td></tr><tr><td>Sensitivity PCR (Median, CI)</td><td>0.960 (0.862, 0.998)</td><td>0.961 (0.859, 0.998)</td></... | <table><tr><td>Uniform</td></tr><tr><td>Peripheralc</td></tr><tr><td>0.504 (0.397, 0.646)</td></tr><tr><td>0.953 (0.841, 0.998)</td></tr><tr><td>0.971 (0.951, 0.986)</td></tr><tr><td>0.964 (0.906, 0.998)</td></tr><tr><td>0.334 (0.252, 0.412)</td></tr><tr><td>0.094 (0.049, 0.150)</td></tr></table> |
1203bd5de6e6099ac4bfa7c1021a2b9358967a1e39db2ab79aadc903b29aa84b.png | complex | <table><tr><td rowspan="3"><i>Group</i></td><td colspan="9"><i>Frequency (kHz)</i></td></tr><tr><td><i>0.5</i></td><td><i>0.7</i></td><td><i>1.0</i></td><td><i>1.4</i></td><td><i>2.0</i></td><td><i>3.0</i></td><td><i>4.0</i></td><td><i>5.0</i></td><td><i>6.0</i></td></tr><tr><td>With stimuli</td><td>9.2±4.5</td><t... | <table><tr><td rowspan="3">Group</td><td colspan="9">Frequency (kHz)</td></tr><tr><td>0.5</td><td>0.7</td><td>1.0</td><td>1.4</td><td>2.0</td><td>3.0</td><td>4.0</td><td>5.0</td><td>6.0</td></tr><tr><td colspan="9"></td></tr><tr><td>With stimuli</td><td>9.2±4.5</td><td>12.5±5.1</td><td>12.1±5.3</td><td>13.4±6.1</td><td... | <table><tr><td>Without stimuli</td><td>9.7±5.0</td><td>12.0±5.9</td><td>12.4±5.6</td><td>13.6±5.9</td><td>7.7±6.2</td><td>5.6±6.0</td><td>4.4±5.0</td><td>2.9±77</td><td>-0.4±7.8</td></tr><tr><td>P value</td><td>0.452</td><td>0.357</td><td>0.433</td><td>0.627</td><td>0.716</td><td>0.863</td><td>0.310</td><td>0.966</td><... |
543c40df3e9350a9e7faf4410033c7523351fb351d99dc36e27bca111b878337.png | simple | <table><tr><td> Logistic portion of the ZIP model</td><td></td><td></td><td></td></tr><tr><td></td><td><i>Model 4</i></td><td><i>Model 5</i></td><td><i>Model 6</i></td></tr><tr><td>Lifetime Earnings<sup>§</sup></td><td>.55*(.28, .91)</td><td>1.08(.81, 1.42)</td><td>1.10(.80, 1.51)</td></tr><tr><td>Gender</td><td><... | <table><tr><td>Logistic portion of the ZIP model</td><td></td><td></td><td></td></tr><tr><td></td><td>Model 4</td><td>Model 5</td><td>Model 6</td></tr><tr><td>Lifetime Earnings§</td><td>.55*(.28, .91)</td><td>1.08(.81, 1.42)</td><td>1.10(.80, 1.51)</td></tr><tr><td>Gender</td><td></td><td>1.15(.50, 2.64)</td><td>1.16(.... | <table><tr><td>High School/GED</td><td></td><td></td><td>.26(.06, 1.06)</td></tr><tr><td>Some College or more</td><td></td><td></td><td>1.76(.63, 4.89)</td></tr></table> |
4e3842a5c332de176d75a7eb0b2265e11791589817fdff80e8c4924f5b1639ac.png | simple | <table><tr><td>MolNo.</td><td>R1</td><td>R2</td><td>Predicted activity</td><td>Lipinski’s scoreandScreen</td></tr><tr><td>R-1</td><td>4-nitrophenyl</td><td>4-methoxyphenyl</td><td>0.8564</td><td>ADRXWS (6)</td></tr><tr><td>R-2</td><td>4-nitrophenyl</td><td>4-nitrophenyl</td><td>-0.3876</td><td>ADRXWS (6)</td></tr... | <table><tr><td>MolNo.</td><td>R1</td><td>R2</td><td>Predicted activity</td><td>Lipinski’s scoreandScreen</td></tr><tr><td>R-1</td><td>4-nitrophenyl</td><td>4-methoxyphenyl</td><td>0.8564</td><td>ADRXWS (6)</td></tr><tr><td>R-2</td><td>4-nitrop</td><td>4-nitrophen</td><td>-0.387</td><td>ADR</td></tr></table> | <table><tr><td></td><td>henyl</td><td>yl</td><td>6</td><td>XWS (6)</td></tr><tr><td>R-3</td><td>Benzyl</td><td>4-hydroxyphenyl</td><td>0.9765</td><td>ADRXWS (6)</td></tr><tr><td>R-4</td><td>3-aminophenyl</td><td>4-nitrophenyl</td><td>0.8450</td><td>ADRXWS (6)</td></tr></table> |
4b62e20b343271ddc1ffb4dc1efef5013fab7fcb19e154241bd3233c81482996.png | simple | <table><tr><td>Percent of invaded area</td><td>Himalayan blackberry</td><td>English ivy</td></tr><tr><td>In clusters</td><td>98.5</td><td>99.3</td></tr><tr><td>In outliers</td><td>1.5</td><td>0.7</td></tr></table> | <table><tr><td>Percent of invaded area</td></tr><tr><td>In clusters</td></tr><tr><td>In outliers</td></tr></table> | <table><tr><td>Himalayan blackberry</td><td>English ivy</td></tr><tr><td>98.5</td><td>99.3</td></tr><tr><td>1.5</td><td>0.7</td></tr></table> |
9fe927fa9f651ac62848eb7e5d90566a1ffc5e6ea488faba361e8ddc0769b7a2.png | complex | <table><tr><td></td><td></td><td colspan="2">MB</td><td colspan="2">no-MB</td></tr><tr><td></td><td></td><td>Pre- training</td><td>Post-training</td><td>Pre- training</td><td>Post-training</td></tr><tr><td>LBD</td><td>Subacute</td><td>63.4 ± 3.1</td><td>61.8 ± 3.1</td><td>63.9 ± 3.1</td><td>64.7 ± 3... | <table><tr><td></td><td></td><td colspan="2">MB</td><td colspan="2">no-MB</td></tr><tr><td></td><td></td><td>Pre- trainin</td><td>Post-</td><td>Pre- </td><td>Post</td></tr></table> | <table><tr><td></td><td></td><td>g</td><td>training</td><td>training</td><td>-training</td></tr><tr><td>LBD</td><td>Subacute</td><td>63.4 ± 3.1</td><td>61.8 ± 3.1</td><td>63.9 ± 3.1</td><td>64.7 ± 3.1</td></tr><tr><td></td><td>Chronic</td><td>69.2 ± 2.6</td><td>65.5 ± 2.6</td><td>67.4 ± 2.6</td><td>67.8 ± 2.6</td></tr>... |
161f69d69b8b3cd48711bff14d537cb9dab55ea4cec60db0987eaf6f34e3c1ed.png | simple | <table><tr><td>KDQOL-36TM Subscales</td><td>Mean</td><td>SD</td><td>Minimal (Floor%)</td><td>Maximal (Ceiling%)</td></tr><tr><td>Symptoms/problems list</td><td>74.22</td><td>15.24</td><td>37.50 (1)</td><td>100 (2.9)</td></tr><tr><td>Effects of kidney disease</td><td>54.78</td><td>20.10</td><td>00.00 (1)</td><td>96.88 (... | <table><tr><td>KDQOL-36TM Subscales</td><td>Mean</td><td>SD</td><td>Minimal (Floor%)</td><td>Maximal (Ceiling%)</td></tr><tr><td>Symptoms/problems list</td><td>74.22</td><td>15.24</td><td>37.50 (1)</td><td>100 (2.9)</td></tr><tr><td>Effects of kidney disease</td><td>54.78</td><td>20.10</td><td>00.00 (1)</td><td>96.88 (... | <table><tr><td>KDQOL-36TM Subscales</td><td>Mean</td><td>SD</td><td>Minimal (Floor%)</td><td>Maximal (Ceiling%)</td></tr><tr><td>Burden of kidney disease</td><td>33.07</td><td>23.31</td><td>00.00 (13.6)</td><td>100 (1)</td></tr><tr><td>Physical Composite Sore</td><td>36.60</td><td>7.83</td><td>17.05 (1)</td><td>54.92 (... |
347a93f7e7906b4626281d92e33a4034712e08922fcf255294b79d23dc1f6425.png | simple | <table><tr><td>VARIABLE/CLUSTER</td><td>CLUSTER 1: "Highest Risk"</td><td>CLUSTER 2: "At Risk"</td><td>CLUSTER 3: "Right Behavior/Wrong Results"</td><td>CLUSTER 4: "Getting Best Results"</td><td>CLUSTER 5: "Doing OK"</td><td>P value<sup>a</sup></td></tr><tr><td><i>Gender </i>(% female)</td><td>53.0</td><td>45.6</td><td... | <table><tr><td>VARIABLE/CLUSTER</td><td>CLUSTER 1: "Highest Risk"</td><td>CLUSTER 2: "At Risk"</td><td>CLUSTER 3: "Right Behavior/Wrong Results"</td><td>CLUSTER 4: "Getting Best Results"</td><td>CLUSTER 5: "Doing OK"</td><td>P valuea</td></tr><tr><td>Gender (% female)</td><td>53.0</td><td>45.6</td><td>59.8</td><td>72.2... | <table><tr><td>Children (% has children)</td><td>37.3</td><td>45.3</td><td>48.2</td><td>45.5</td><td>32.8</td><td>0.216</td></tr><tr><td>Employment (%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Employed</td><td>53.0</td><td>46.0</td><td>43.5</td><td>58.2</td><td>79.3</td><td>0.000 ***</td><... |
fc47884a6981863692f8f11b8b9020a68ef56a76e935f220c3f1cfaa12576d2c.png | simple | <table><tr><td>Measure</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>1. PCL-F</td><td>--</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2. PCL-F symptom group B</td><td>0.73 ***</td><td>--</td><td></td><td></td><td></td><td></td><td></t... | <table><tr><td>Measure</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>1. PCL-F</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td></td><td>--</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2. PCL-F symptom group B</td><td>0.73 ***</td><td>--</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>3. PCL-F symptom group C</td><td>0.90 ***</td><td>0.45 ***</td><td>--</td><td></td><td></... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.